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Introduction and aims

Chapter 1
Background
The three compartments of the knee joint allow for seven possible patterns of 
osteoarthritis. Isolated patellofemoral, isolated medial femorotibial, and combined 
medial femorotibial and patellofemoral osteoarthritis have been identified as the 
most common patterns in patients with knee complaints (McAlindon et al. 1992, 
Davies et al. 2002). The reported radiological prevalence of isolated patellofemoral 
osteoarthritis varies between 4% and 24%, the prevalence of clinically important 
isolated patellofemoral osteoarthritis is not known (Barrett, Jr. et al. 1990, 
McAlindonetal. 1992, Davies etal. 2002). Three etiological groups of patellofemoral 
osteoarthritis are recognised: posttraumatic patellofemoral osteoarthritis, 
patellofemoral osteoarthritis with a history of patellofemoral instability, and primary 
patellofemoral osteoarthritis (Argenson et al. 1995).
Mild isolated patellofemoral osteoarthritis is significantly associated with pain, 
stiffness, and functional limitation (Hunter et al. 2003, Duncan et al. 2009). The 
diagnosis is based on a typical history of anterior knee pain after prolonged 
sitting or upon rising from a chair, and pain when descending and ascending 
stairs. The pain is characteristically less severe when walking on level ground. 
Clinical findings are not specific, and include quadriceps wasting, pain, and 
crepitus emanating from the anterior compartment (Iwano et al. 1990, Donell and 
Glasgow2007). Findings of patellofemoral instability are common. The radiological 
findings include patellofemoral joint space narrowing and osteophyte formation 
on lateral and axial (skyline) knee radiographs, chondral lesions and subchondral 
changes on magnetic resonance imaging (MRI) studies, and increased uptake on 
technetium-99m bone scans (Boegard et al. 1998, Leadbetter et al. 2005, 
McDonnell et al. 2009).
Initially, patients with isolated patellofemoral osteoarthritis can be treated with a 
nonoperative approach, such as activity modification, weight loss, oral and intra- 
articular medications, and physical therapy, although it is unclear which specific 
conservative treatment should be recommended (Donell and Glasgow 2007). A 
multitude of operative treatment modalities have been used in patients with 
disabling complaints unresponsive to non-surgical treatment (Saleh et al. 2005, 
Grelsamer and Stein 2006). These modalities include partial lateral facetectomy, 
distal realignment procedures, lateral retinacular release, patellectomy, and 
partial or total knee replacement. Primary total knee replacement with or without
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patellar resurfacing leads to predictable and durable good results; however, 7 to 
19% of patients have reported anterior knee pain after total knee replacement for 
Isolated patellofemoral osteoarthritis (Laskln and Van Steljn 1999, Parvlzl et al. 
2001, Mont et al. 2002, Medlng et al. 2007). Moreover, total knee replacement Is 
probably too aggressive of a treatment for what Is, In effect, a disease confined to 
one compartment.
Patellofemoral joint replacement was Introduced In 1948 as an alternative to 
patellectomy, which led to poor cosmetic and functional outcomes (McKeever 
1955). Several prosthetic designs have been used with varying results. Many of 
the failures resulted from a combination of poor patient selection and the 
geometric properties of the trochlear component (Lonner 2008). Identifying the 
proper Indications and contra-lndlcatlons, together with design Improvements, 
has led to results that are comparable to those achieved after primary total knee 
replacement, albeit with a significantly less Intrusive surgical procedure 
(Leadbetter et al. 2005, Leadbetter et al. 2006).
The development of painful femorotlblal osteoarthritis Is the most Important non- 
prosthesls-related reason for conversion to total knee replacement (Kooljman et 
al. 2003). Predictive factors have yet to be Identified, and the question remains 
how to Improve the selection criteria. Obviously, unicompartmental joint 
replacement will always be associated with the risk of developing osteoarthritis In 
other compartments. Although conversion to total knee replacement for failed 
patellofemoral joint replacement Improves the clinical outcome, It Is not known If 
these results are comparable to those achieved after primary total knee 
replacement (Lonner et al. 2006). Furthermore, the results of conversion may be 
compromised by loss of bone behind the anterlorflange of the femoral component 
and by technical difficulties during conversion, as this Is a known Issue with 
revision of total knee replacements (van Loon et al. 1999, Huff and Sculco 
2007).
Despite numerous studies In recent years, the Issue of whether or not to resurface 
the patella during primary total knee replacement remains unresolved (Calvlsl et 
al. 2009). According to the 2009 Annual Report of the Swedish Knee Arthroplasty 
Register, patellar resurfacing Is used In less than 10% of TKA cases In Sweden, 
70% of cases In Denmark, 5% In Norway, and 45% of cases In Australia (The 
Swedish Knee Arthroplasty Register 2009). Other strategies to reduce the
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prevalence of anterior knee pain after total knee replacement Include electrocautery 
of the patellar rim, patelloplasty, and selective resurfacing (Barrack and Burak 
2001, Saoud 2004, McPherson 2006). In contrast, there have been no published 
reports on the outcome of patellofemoral joint replacement without patellar 
resurfacing.
Aims of the thesis
The alms of this thesis are as follows:
■ To clarify the role of nonoperative and operative treatment modalities In Isolated 
patellofemoral osteoarthritis;
■ To evaluate the long-term outcomes of a patellofemoral prosthesis, and to 
Identify the different failure mechanisms;
■ To Investigate whether prior patellofemoral joint replacement has an effect on 
the clinical outcome of later conversion to total knee replacement for femorotlblal 
osteoarthritis;
■ To evaluate the possible loss of distal femoral bone after patellofemoral joint 
replacement;
■ To Investigate the efficacy of clrcumpatellar electrocautery In total knee 
replacement.
Outline of the thesis
In Chapter 2, we present a systematic review on nonoperative and operative 
treatment options for Isolated patellofemoral osteoarthritis. We assessed the 
quality of Included studies with the Grading of Recommendations Assessment, 
Development, and Evaluation (GRADE) approach (Atkins et al. 2004). In addition 
to describing the overall methodological quality of the studies (high, moderate, 
low or very low), we provide a strong or weak recommendation for or against the 
use of specific Interventions.
Chapter 3 describes the long-term outcomes of the Richards II patellofemoral 
prosthesis used In Deventer from 1976 onwards (Sllngenberg and Drlessen 1982, 
Werkman 1991). We Investigated whether preoperative diagnosis Influenced 
long-term Implant survival, and correlated surgical outcomes with age, sex, and
13
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body mass index (BMI). We also identified the main modes of failure of the 
Richards II patellofemoral prosthesis.
In Chapter 4, we assess the clinical results of conversion of patellofemoral joint 
replacement to total knee replacement for painful femorotibial osteoarthritis. We 
investigated, in a matched case-control study, whether these results were 
comparableto those achieved after primarytotal knee replacementforfemorotibial 
osteoarthritis.
In Chapters 5 and 6, we present radiological and numerical data regarding the 
possible loss of bone behind the anterior flange of the femoral component of a 
patellofemoral prosthesis. Dual-energy X-ray absorptiometry (DXA) measurements 
were performed in patients undergoing patellofemoral joint replacement, and 
finite element analysis was employed to evaluate the likelihood of stress 
shielding.
In Chapter 7, we present the results of a postal questionnaire that we used in The 
Netherlands to assess the use of circumpatellar electrocautery in total knee 
replacement. Electrocautery of the patellar rim is employed by some orthopaedic 
surgeons to reduce the prevalence of anterior knee pain after total knee 
replacement.
In Chapter 8, we studied the clinical efficacy of circumpatellar electrocautery in 
primary total knee replacement without patellar resurfacing with respect to the 
prevalence of anterior knee pain and standardised clinical and patient-reported 
outcomes.
Finally, Chapter 9 summarises the studies described in this thesis with a general 
discussion and final conclusions.
14
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Isolated patellofemoral osteoarthritis:
A systematic review of treatment options using 
the GRADE approach
van Jonbergen H P W, Poolman R W, van Kampen A.
Acta Orthop 2010; 81: 199-205.
Treatment options for isolated patellofem oral osteoarthritis
Abstract
Background and purpose: The optimal treatment for isolated patellofemoral 
osteoarthritis is unclear at present. We systematically reviewed the highest level 
of available evidence on the nonoperative and operative treatment of isolated 
patellofemoral osteoarthritis to develop an evidenced-based discussion of 
treatment options.
Methods: A systematic computerized database search (Cochrane Database of 
Systematic Reviews, Cochrane Central Register of Controlled Trials, MEDLINE 
(PubMed), and EM BASE) was performed in March 2009. The quality of the studies 
was assessed independently by two authors using the Grading of Recommenda­
tions Assessment, Development and Evaluation (GRADE) approach.
Results: We extracted data from 44 articles. The best available evidence for 
treatment of isolated patellofemoral osteoarthritis is sparse and of generally low 
methodological quality. Nonoperative treatment using physiotherapy (GRADE: 
high quality, weak recommendation for use), taping (GRADE: moderate quality, 
weak recommendation for use), or injection therapy (GRADE: very low quality, 
weak recommendation for use) may result in short-term relief. Joint-preserving 
surgical treatment may result in insufficient, unpredictable, or only short-term 
improvement (GRADE: low quality, weak recommendation against use). Total 
knee replacement with patellar resurfacing results in predictable and good, 
durable results (GRADE: low quality, weak recommendation for use). Outcome 
after patellofemoral arthroplasty in selected patients is good to excellent (GRADE: 
low quality, weak recommendation for use).
Interpretation: Methodologically good quality comparative studies, preferably 
using a patient-relevant outcome instrument, are needed to establish the optimal 
treatment strategy for patients with isolated patellofemoral osteoarthritis.
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Introduction
A multitude of nonoperative and operative treatment options have been described 
for isolated patellofemoral osteoarthritis in the literature, but the optimal treatment 
is unclear at present. To develop an evidenced-based discussion of treatment 
options in isolated patellofemoral osteoarthritis, we reviewed the highest level of 
available evidence on the nonoperative and operative treatment of isolated 
patellofemoral osteoarthritis.
Materials and methods
With use of the evidence-based cycle, we formulated 3 focused clinical questions 
with well-articulated Patient/Population (P), Intervention (I), Comparison (C), and 
Outcome (0) (PICO) elements (Poolman et al. 2007a). The questions were as follows.
1. In patients with isolated patellofemoral osteoarthritis (P), is physical therapy (I) 
better than no physical therapy (C) when assessed with a validated outcome 
measure (0)?
2. In patients with isolated patellofemoral osteoarthritis (P), is operative treatment 
(I) better than nonoperative treatment (C) when assessed with a validated 
outcome measure (0)?
3. In patients with isolated patellofemoral osteoarthritis (P), is patellofemoral 
arthroplasty (I) betterthan other operative treatment options (C) when assessed 
with a validated outcome measure (0)?
Criteria for eligibility
We searched for studies that fulfilled certain inclusion criteria. Publications in the 
English, French, Dutch, or German language that describe the clinical outcome of 
nonoperative or operative treatments for isolated patellofemoral osteoarthritis in 
10 or more patients were included. Publications reporting the results of treatment 
of patellofemoral pain syndrome without osteoarthritis were excluded, as were 
studies with incompletely described patient populations, insufficient descriptions 
of treatment, and studies lacking the use of validated or commonly used outcome 
measures.
19
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Study identification
Using the following search terms with Boolean operators ([femoropatell* OR femoro- 
patell* OR patell*] AND [osteoarthritis OR arthritis OR arthrosis]), we conducted 
the following searches:
1. Computerized database searches of:
a. the Cochrane Database of Systematic Reviews (2009, Issue 1);
b. the Cochrane Central Register of Controlled Trials (2009, Issue 1);
c. MEDLINE (PubMed) (1966 to 6 March 2009) using the “clinical queries” 
feature with a “broad search” for “therapy”;
d. EMBASE (1966 to 7 March 2009) using a search strategy with “Include 
sub-terms/derivatives” and “Record limits: Humans”.
2. Reviews of the bibliographies of eligible articles.
The systematic search was performed in March 2009 with adherence to the 
QUOROM statement and the MOOSE guidelines (Moher et al. 1999, Stroup et al. 
2000). The search was performed in duplicate by one of the authors (HPWvJ) and 
a librarian. Authors of eligible studies were not contacted with regard to possible 
unpublished results.
Evaluation of methodological quality
The quality of the studies included was assessed independently by two authors 
(HPWvJ, RWP) using the Grading of Recommendations Assessment, Development 
and Evaluation (GRADE) approach (www.gradeworkinggroup.org) (Atkins et al.
2004, Petrisor et al. 2006, Guyatt et al. 2008). Apart from describing the 
methodological quality of the studies (high, moderate, low or very low), a strong 
or weak recommendation was given for or against the use of an intervention. 
A strong recommendation for using an intervention was given when the benefits 
clearly outweighed the risks for most if not all patients, with high-quality evidence 
supporting that recommendation. However, a strong recommendation against 
use may also be supported by studies of low-grade quality, such as case series 
that show serious adverse effects of the intervention (Poolman et al. 2007b). 
A weak recommendation for or against use of an intervention was given where the 
risks and benefits were more closely balanced or were more uncertain because 
of the low methodological quality of the supporting studies.
Data abstraction
Relevant data regarding study design, study population, intervention, and outcome 
measures were extracted from the text, figures, and tables of the articles included.
20
Chapter 2
Results
44 studies, all of which were published as full journal articles, met the eligibility 
criteria and were included in this review (Figure and Table).
Figure QUOROM flow diagram of included studies
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Table GRADE evidence profile: nonoperative and operative treatment for isolated patellofemoral osteoarthritis.
Quality assessment Summary of findings  
Number of patients Effect Quality
Recommendation
Number
of
studies
Design Lim itations Inconsistency Indirectness Imprecision Publication
bias
Treatment Control Absolute  
(95% Cl) a
Nonoperative treatment: Physiotherapy versus no physiotherapy
1 R a n d o m iz e d  tr ia l N o  s e r io u s  
lim ita t io n s
o n ly  o n e  s tu d y N o  s e r io u s  
In d ire c tn e s s
N o  se r io u s  
Im p re c is io n
U n d e te c te d 40 43 K n e e  p a in  at 5 
m o n th s  ( -6 .4  
m m ; 95%  Cl 
-1 5 .3  to  2.4; 
p = 0 .16 )
In c re ased  
q u a d r ic e p s  
s tre n g th  a t 5 
m o n th s  (+11.7 
N m ; 95%  Cl 
4 .5 to  19.0; 
p = 0 .0 0 2 )
W O  M A C  at 5 
m o n th s  (-0 .6 ; 
9 5%  Cl -3 .7  to  
2.4; p = 0 .6 8 )
e®ee
H IG H
W e a k  for
Nonoperative treatment: Taping
1 R a n d o m iz e d  
c ro s s o v e r tria
S e r io u s  (-1) b o n ly  o n e  s tu d y N o  s e r io u s  
in d ire c tn e s s
N o  se r io u s  
Im p re c is io n
U n d e te c te d 14 (14) N e u tra l vs 
m e d ia  ta p in g  
kn e e  p a in  at 4 
d a ys  (15.5 m m ; 
9 5%  Cl 2.4 to  
28 .6 ; p = 0 .0 2 3 )
N e u tra l vs 
la te ra l ta p in g  
kn e e  p a in  at 4 
d a ys  (-8 .0 m m ; 
95% C I - 2 2 .5  to  
6 .5 , p = '0 .26)
ffi©ffiO
M O D E R A T E
W e a k  for
Nonoperative treatment: Intra-articular injection
1 O b s e rv a t io n a l S e r io u s  (-1 )c o n ly  o n e  s tu d y N o  s e r io u s  
In d ire c tn e s s
N o  se r io u s  
Im p re c is io n
U n d e te c te d 25 ©ooo
V E R Y  LO W
W e a k  for
Operative treatment: Arthroscopy
2 R a n d o m iz e d  tr ia l N o  s e r io u s  
lim ita t io n s
N o  s e r io u s  
in c o n s is te n c y
S o m e
u n c e rta in ty
a b o u t
d ire c tn e s s
H ) d
N o  se r io u s  
Im p re c is io n
U n d e te c te d 196 135 K S P S  a t 24 
m o n th s  (p la c e b o  
51 .6 ± 2 3 .7 ; 
lavag e  
5 3 .7 ± 2 3 ,7 ; 
d e b r id e m e n t 
5 1 .4 ± 2 3 .2 ; 
p = 0 .6 4  and 
p = 0 .9 6 )e
W O  M A C  at 
24 m o n th s  
( -2 3 ± 6 0 5 ;  95%  
Cl - 2 0 8  to  161 
p = 0 .2 2 )
®0®O
M O D E R A T E
S tro n g  a g a in s t
Operative treatment: Chondroplasty, resection arthroplasty, and lateral facetectomy
5 O b s e rv a t io n a l N o  s e r io u s  
lim ita t io n s
N o  s e r io u s  
In c o n s is te n c y
N o  s e r io u s  
in d ire c tn e s s
N o  se r io u s  
Im p re c is io n
U n d e te c te d 155 ©eoo
L O W
W e a k  for
Operative treatment: Extensor mechanism alignment and lateral release
7 O b s e rv a t io n a l N o  s e r io u s  
lim ita t io n s
N o  s e r io u s  
in c o n s is te n c y
N o  s e r io u s  
In d ire c tn e s s
N o  se r io u s  
Im p re c is io n
U n d e te c te d 224 ©®oo
L O W
W e a k  a g a in s t
Operative treatment: Patellectomy
0
Operative treatment: Total knee arthroplasty
6 M a tc h e d  
c a s e  c o n tro l 
o b s e rv a tio n a l
N o  s e r io u s  
lim ita t io n s
N o  s e r io u s  
In c o n s is te n c y
N o  s e r io u s  
in d ire c tn e s s
N o  se r io u s  
Im p re c is io n
U n d e te c te d 271 ©eoo
L O W
W e a k  for
Operative treatment: Patellofemoral arthroplasty
24 S y s te m a tic
review ,
o b s e rv a tio n a l
N o  s e r io u s  
lim ita t io n s
N o  s e r io u s  
in c o n s is te n c y
N o  s e r io u s  
In d ire c tn e s s
N o  se r io u s  
Im p re c is io n
U n d e te c te d 2 9 3 8 ©eoo
L O W
W e a k  fo r
a 95% Cl = 95% confidence Interval,
b patients not blinded, short follow-up.
c pilot study, Important heterogeneity In diagnosis,
d not specifically limited to Isolated patellofemoral osteoarthritis.
ino e KSPS = Knee Specific Pain Score.
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Results relating to the 3 focused, patient-oriented clinical questions developed 
using PICO were as follows. One randomized controlled trial described the 
short-term outcome of physical therapy compared with no physical therapy 
(Qullty et al. 2003). We were unable to Identify studies that directly compared the 
results of operative and nonoperative treatments. Also, no comparative studies 
were retrieved that directly compared the results of patellofemoral arthroplasty 
with the results of other operative treatment options.
Due to the heterogeneity of the study designs and outcome measures, a meta- 
analysls was not performed. The following review of the literature Is therefore 
descriptive.
Highest available evidence
1. Nonoperative treatment:
a. Physical therapy versus no physical therapy: 1 randomized controlled trial 
(83 patients) (Qullty et al. 2003)
b. Taping: 1 randomized cross-over trial (14 patients) (Cushnaghan et al. 1994)
c. Intra-artlcular Injection: 1 prospective case series (25 patients) (Clarke et al.
2005)
2. Nonoperative versus operative treatment:
a. No comparative studies Identified
3. Operative treatment:
a. Arthroscopy: 2 randomized controlled trials (165 and 168 patients) were 
Included based on Indirect evidence (Moseley et al. 2002, Klrkley et al. 2008)
b. Chondroplasty, resectlon-arthroplasty, and lateralfacetectomy: 1 prospective 
case series (50 patients) (Becker et al. 2008), and 4 retrospective case 
series (11-63 patients) (Beltran 1987, Yercan et al. 2005, Spak and Teltge 
2006, Paulos et al. 2008)
c. Extensor mechanism alignment and lateral release: 2 prospective case series 
(35 and 50 patients) (Becker et al. 2008, Alemdaroglu et al. 2008),
2 retrospective comparative studies (12 and 48 patients) (Weaver et al. 1991, 
Jacquot et al. 2004), and 3 retrospective case series (14-50 patients) 
(Aderlnto and Cobb 2002, Kohn et al. 2004, Caroflno and Fulkerson 2008)
d. Patellectomy: no studies met the Inclusion criteria
e. Total knee arthroplasty: 2 matched case-control studies (94 and 54 patients) 
of total knee arthroplasty for Isolated patellofemoral osteoarthritis compared 
with total knee arthroplasty for tn-compartmental osteoarthritis (Laskln and
24
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Van Steijn 1999, Meding et al. 2007), 1 prospective case series (24 patients) 
(Parvlzl et al. 2001), and 3 retrospective case series (25-47 patients) (Mont 
et al. 2002, Dejour et al. 2004, Dalury 2005)
f. Patellofemoral arthroplasty: 3 systematic reviews of case series (538-812 
patients) (Leadbetter et al. 2005, Leadbetter et al. 2006, Becher et al. 2008), 
5 prospective case series (15-240 patients) (Arnbjornsson and Ryd 1998, 
Tauro et al. 2001, Merchant 2004, Ackroyd and Chlr 2005, Ackroyd et al. 
2007), and 16 retrospective case series (12-65 patients) (Arderò and Toomey 
1988, Cartier et al. 1990, Argenson et al. 1995, Krajca-Radcllffe and Coker 
1996, Mertl et al. 1997, Fink et al. 1999, de Cloedt et al. 1999, de Winter et al.
2001, Smith et al. 2002, Kooljman et al. 2003, Board et al. 2004, Cartier et al. 
2005, Argenson et al. 2005, Merchant 2005, Sisto and Sarln 2006, Gadeyne 
et al. 2008).
The available evidence together with background Information from systematic 
reviews and other relevant sources was used for the following discussion of 
treatment options.
Nonoperative treatment options 
Physiotherapy
Initially, patients with Isolated patellofemoral osteoarthritis can be treated using a 
nonoperative approach such as activity modification, weight loss, and physio­
therapy. One randomized controlled trial described the short-term outcome of a 
commonly used physiotherapy package (patellar taping, functional exercises, 
quadriceps strengthening exercises, postural advice, and education) compared 
with no physical therapy (Qullty et al. 2003). The physiotherapy Intervention was 
delivered by a single physiotherapist In nine 30-mlnute sessions over 10 weeks, 
with advice to continue thereafter. The treatment group had a small reduction In 
pain and a substantial Increase In the quadriceps strength of the Index knee 10 
weeks after treatment compared with the no-treatment group. After 12 months, no 
differences In patient-relevant outcome measures were noted between groups 
(Qullty et al. 2003). According to GRADE, the quality of this evidence Is high, with 
a weak recommendation for use of the Intervention.
Taping
A randomized crossover trial using visual analog scale ratings for pain 
demonstrated a 25% reduction In knee pain when the patella was taped medially. 
However, each tape (medial, lateral, or neutral) was applied for only 4 days, with
25
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3 days of no treatment between tape positions (Cushnaghan et ai. 1994). 
According to GRADE, the quality of the evidence is moderate, with a weak 
recommendation for use of this intervention.
Intra-articular injections / visco-supplementation
The clinical effect of intra-articular visco-supplementation with hylan G-F 20 (Synvisc; 
Genzyme Corporation, Cambridge, MA) was assessed in a non-randomized 
clinical trial with use of a patient-relevant outcome instrument. Pain upon stair 
climbing improved 4 weeks after the initial injection and the improvement was 
maintained to 26 and 52 weeks (Clarke et al. 2005). According to GRADE, the 
evidence is of very low quality, with a weak recommendation for use of this 
intervention.
Operative treatment options 
Arthroscopy
We did not identify any studies describing the results of arthroscopic debridement 
of articular cartilage for patients with isolated patellofemoral osteoarthritis. 
However, we did include 2 methodologically sound randomized controlled trials, 
although they describe the results of arthroscopy in osteoarthritis of the knee, 
and were not specifically limited to isolated patellofemoral osteoarthritis (Moseley 
et al. 2002, Kirkley et al. 2008). No differences in outcome were found between 
surgical placebo treatment and arthroscopy, and between arthroscopy combined 
with physiotherapy as opposed to nonoperative treatment with physiotherapy 
only. Although these papers do not strictly describe the results of arthroscopic 
treatment for isolated patellofemoral osteoarthritis, indirect evidence is given. 
Based on these high-quality studies, arthroscopy is not recommended for 
osteoarthritis of the knee. In the case of indirect evidence, the GRADE group 
advises reducing the level of quality from high to moderate (Guyatt et al. 2008), 
with a strong recommendation against the use of this intervention.
Chondroplasty, resection-arthroplasty, and lateral facetectomy
A retrospective case series in patients younger than 55 years of age showed that 
the use of fresh osteochondral allografts for patellofemoral arthritis resulted in 
relief of the arthritic condition, improved knee function, and delayed prosthetic 
knee replacement (Spak and Teitge 2006). A retrospective case series describing 
the results of en bloc removal of articular cartilage and subchondral bone showed 
that 20 of the 33 operated knees were pain-free after an average of 31-months of
26
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follow-up (Beltran 1987). Partial lateral facetectomy results In short-term 
Improvement In pain scores with no or moderate Improvement In function, as 
assessed with a patient-relevant outcome Instrument (Yercan et al. 2005, Becker 
et al. 2008, Paulos et al. 2008). According to GRADE, the evidence Is of low 
quality, with a weak recommendation for use of these Interventions.
Extensor mechanism alignment and lateral release
Anterior displacement of the tlblal tuberosity reduces the contact forces, but not 
necessarily the stress on the patellofemoral joint (Lewallen et al. 1990). Anterome- 
dlallzatlon, which translates the contact area medially, results In relief of the lateral 
facet which could theoretically reduce pain. Retrospective case series evaluating 
the 2- to 6-year results of anteromedlal transfer of the tlblal tuberosity combined 
with lateral retlnacular release have demonstrated an Improvement In outcome 
measures with reduced pain (Weaver et al. 1991, Kohn et al. 2004, Caroflno and 
Fulkerson 2008). Total loss of cartilage or absence of lateralization are contra­
indications to the Fulkerson procedure (Stelmer and Kohn 2007). Compared with 
medlallzatlon with vastus medlalls obllquus shortening, anterior displacement 
and lateral facetectomy both result In Improved knee function (Jacquot et al. 
2004). However, the number of complications associated with the Maquet anterior 
displacement Is high (Kadambande et al. 2004). Combined partial lateral 
facetectomy, lateral release, and medlallzatlon of the tlblal tubercle result In 
Incomplete Improvement of symptoms as assessed with a patient-relevant 
outcome Instrument (Becker et al. 2008). In a large number of patients, Isolated 
arthroscopic lateral retlnacular release results In reduction of pain rather than 
resolution (Aderlnto and Cobb 2002, Alemdaroglu et al. 2008). In evaluating the 
results, a patient-relevant outcome Instrument was used. According to GRADE, 
the evidence Is of low quality, with a weak recommendation against use of these 
Interventions.
Total knee arthroplasty
Total knee replacement with patellar resurfacing gives satisfactory 5- to 7-year 
results In patients with Isolated patellofemoral osteoarthritis (Laskln and Van 
Steljn 1999, Parvlzl et al. 2001, Mont et al. 2002, Dejour et al. 2004, Dalury 2005, 
Medlng et al. 2007). These results are similar to those achieved after total knee 
arthroplasty with patellar resurfacing for femorotlblal osteoarthritis (Laskln and 
Van Steljn 1999, Medlng et al. 2007). However, up to one-fifth of patients have 
reported anterior knee pain after total knee replacement (Laskln and Van Steljn
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1999, Parvizi et al. 2001, Mont et al. 2002, Meding et al. 2007). As with total knee 
arthroplasty for tricompartmental osteoarthritis, it remains unclear whether 
patellar resurfacing results in better outcomes in isolated patellofemoral 
osteoarthritis (Thompson et al. 2001). Because of its relationship with patellofemoral 
instability, total knee arthroplasty in patients with isolated patellofemoral 
osteoarthritis is a technically more demanding procedure (Laskin and Van Steijn 
1999, Parvizi et al. 2001, Mont et al. 2002, Saleh et al. 2005). According to GRADE, 
the evidence is of low quality, with a weak recommendation for use of this 
intervention.
Patellofemoral arthroplasty
In patellofemoral arthroplasty, the femorotibial compartments with cruciate 
ligaments and menisci are spared, which probably allows preservation of 
physiological femorotibial joint mechanics. The clinical results reported are 
related to prosthetic design, surgical technique, patient selection and indication, 
and length of follow-up, and have shown good to excellent 3- to 17-year results in 
two-thirds of patients to all of them (Arciero and Toomey 1988, Cartier et al. 1990, 
Argenson et al. 1995, Krajca-Radcliffe and Coker 1996, Mertl et al. 1997, 
Arnbjornsson and Ryd 1998, de Winter et al. 2001, Smith et al. 2002, Kooijman et 
al. 2003, Merchant 2004, Merchant 2005, Ackroyd and Chir 2005, Cartier et al.
2005, Sisto and Sarin 2006, Ackroyd et al. 2007, Gadeyne et al. 2008). Progression 
of femorotibial osteoarthritis, malposition of the prosthesis, and wear or loosening 
may result in failure of the patellofemoral arthroplasty (Leadbetter et al. 2005). 
Development of painful femorotibial osteoarthritis is the most important non- 
prosthetic-related reason for conversion to total knee arthroplasty. Conversion 
rates of 1 in 5 have been reported after an average of 7 to 16 years (Kooijman et 
al. 2003, Argenson et al. 2005). It remains unclear which patients are at risk of 
developing femorotibial osteoarthritis (Leadbetter et al. 2005). Recently, the 
results of revision to total knee arthroplasty for progression of femorotibial 
osteoarthritis or malposition was described (Lonner et al. 2006). Clinical outcome 
as assessed by the Knee Society score (KSS) improved after revision. 
Patellofemoral arthroplasty does not have a negative effect on the outcome of 
later total knee arthroplasty (van Jonbergen et al. 2009). According to GRADE, 
the evidence is of low quality, with a weak recommendation for use of this 
intervention.
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Discussion
Several nonoperative and operative treatment options for Isolated patellofemoral 
osteoarthritis have been described. At present, there are no publications describing 
the outcome of nonoperative treatment after 1 year. A multitude of studies of 
generally low methodological quality have reported the short- and long-term 
results of surgical management. Despite these limitations, we present the following 
treatment recommendations based on the best available evidence.
Nonoperative treatment using physical therapy (GRADE: high quality, weak 
recommendation for use), taping (GRADE: moderate quality, weak recommendation 
for use), or Injection therapy (GRADE: very low quality, weak recommendation for 
use) may result In short-term relief. Joint-preserving surgical treatment may result 
In Insufficient, unpredictable, or only short-term Improvement (GRADE: low 
quality, weak recommendation against use). Total knee replacement with patellar 
resurfacing results In predictable and durable good results (GRADE: low quality, 
weak recommendation for use).
However, for a degenerative disease Involving only one compartment, It Is probably 
too aggressive. Outcome after patellofemoral arthroplasty In selected patients Is 
good to excellent (GRADE: low quality, weak recommendation for use). Total knee 
replacement can be performed later If painful femorotlblal osteoarthritis develops.
Strengths and limitations of this review
Our study Is the first systematic review to use both well-articulated patlent-orlent- 
ed clinical questions (PICO) and an evaluation using the GRADE approach In 
order to obtain an evldenced-based discussion of nonoperative and operative 
treatment options In Isolated patellofemoral osteoarthritis.
However, our study has some limitations that should be considered. First, there Is 
always the possibility that we failed to Identify some studies, although a comprehensive 
search strategy was used Including visually searching the reference lists of all eligible 
articles. Secondly, our aim was to evaluate the best evidence on the treatment of 
patellofemoral osteoarthritis, and therefore we did not Include chondromalacia In our 
search strategy. Because there Is currently no consensus on the diagnostic criteria of 
patellofemoral osteoarthritis, It Is possible that we Included studies with Important 
heterogeneity among the degree of osteoarthritis and clinical complaints.
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Limitations of primary research
This systematic review shows that the current best available evidence for treatment 
of isolated patellofemoral osteoarthritis is sparse and generally of low methodo­
logical quality. The lack of randomized, controlled studies may result in substantial 
selection bias. Also, comparison of the results of different treatments is hampered 
by the extensive heterogeneity among the outcome instruments used. Only 4 of 
the 44 studies included employed a patient-relevant outcome instrument such as 
the WOMAC Osteoarthritis Index in evaluating the results of treatment (Quilty et 
al. 2003, Clarke et al. 2005, Alemdaroglu et al. 2008, Becker et al. 2008).
Implications for future research
Methodologically good-quality studies, preferably evaluating results with a 
validated patient-relevant outcome measure such as the KOOS or WOMAC 
(Paxton and Fithian 2005), are needed to establish the optimal treatment strategy 
for patients with isolated patellofemoral osteoarthritis. Ideally, such studies should 
compare the results of commonly advocated methods of nonoperative and 
operative treatments.
Conclusion
The results of this systematic review show that the best available evidence for 
nonoperative and operative treatment options for patients with isolated patello­
femoral osteoarthritis is sparse and of low methodological quality. Presently, there 
is no convincing evidence that one specific treatment modality is superior to 
another in terms of better outcomes.
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Abstract
The purpose of this study was to correlate the long-term survival of patellofemoral 
arthroplasty with primary diagnosis, age, sex, and body mass index. One hundred 
eighty-five consecutive Richards type II patellofemoral arthroplasties were 
performed in 161 patients with isolated patellofemoral osteoarthritis. Diagnoses 
included primary patellofemoral osteoarthritis, posttraumatic patellofemoral 
osteoarthritis, and patellofemoral osteoarthritis with a previous realignment 
procedure for patellar subluxation ortrochlear dysplasia. Median time to follow-up 
was 13.3 (range, 2.0-30.6) years. Patellofemoral arthroplasty survival was 84% at 
10 years and 69% at 20 years. Primary diagnosis, sex, or age at patellofemoral 
arthroplasty did not significantly affect the rate of revision (p=0.35, p=0.24, and 
p = 0.65, respectively). The rate of revision in obese patients (body mass index 
>30 kg/m2) was higher than that in nonobese patients (p = 0.02).
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Introduction
Isolated patellofemoral osteoarthritis Is a relatively common degenerative disorder 
of the knee that occurs In 13.6 to 24% of women and 11 to 15.4% of men olderthan 
55 to 60 years (McAllndon et al. 1992, Davies et al. 2002). Surgical treatment 
should be reserved for the minority of patients with Incapacitating pain and 
functional limitations and for whom nonoperative modalities, such as weight 
reduction and physical therapy, have failed (Leadbetter et al. 2005, Grelsamer 
and Stein 2006). Several surgical approaches have been used to treat Isolated 
patellofemoral osteoarthritis successfully, Including arthroscopic debridement 
with or without lateral release, chondroplasty, unloading procedures with osteotomy 
of the tlblal tuberosity, patellectomy, total knee arthroplasty, and patellofemoral 
replacement (Saleh et al. 2005, Grelsamer and Stein 2006, Lonner 2007).
Although total knee arthroplasty with or without patellar resurfacing gives predictably 
good results for Isolated patellofemoral osteoarthritis (Laskln and Van Steljn 1999, 
Parvlzl et al. 2001, Thompson et al. 2001, Mont et al. 2002), a less aggressive 
approach using patellofemoral arthroplasty may be more appropriate. In contrast 
to total knee arthroplasty, In patellofemoral arthroplasty, only the Involved joint 
compartment Is replaced and the femorotlblal joint with the cruciate ligaments 
and menisci Is spared, thereby preserving more physiologic joint motion.
Several studies have addressed the short-term and midterm results of patello­
femoral arthroplasty (Vermeulen et al. 1973, Blazlna et al. 1979, Arclero and Toomey 
1988, Cartier et al. 1990, Argenson et al. 1995, Krajca-Radcllffe and Coker 1996, 
Arnbjornsson and Ryd 1998, de Winter et al. 2001, Tauro et al. 2001, Smith et al.
2002, Kooljman et al. 2003, Board et al. 2004, Merchant 2004, Ackroyd and Chlr
2005, Merchant 2005, Cartier et al. 2005, Argenson et al. 2005, Slsto and Sarin
2006, Ackroyd et al. 2007). Although authors stress the Importance of patient 
selection, no long-term outcome data regarding optimal preoperative Indications 
or Ideal patient age range are available (Leadbetter et al. 2005, Lonner 2007).
We hypothesized that patients with primary Isolated patellofemoral osteoarthritis 
would demonstrate Implant survival similar to that of patients with posttraumatlc 
patellofemoral osteoarthritis or patellofemoral osteoarthritis with a previous 
realignment procedure for patellar subluxation or trochlear dysplasia. Therefore, 
our primary objective was to correlate survival rates for the patellofemoral prostheses
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with these 3 different diagnostic groups. Secondary objectives were to correlate 
surgical outcomes with the age, sex, and body mass index (BMI), and to identify 
the main modes of failure of Richards type II patellofemoral arthroplasty.
Materials and Methods
Between December 1976 and December 2005, 185 consecutive Richards type II 
(Smith & Nephew, Memphis, Tennessee) patellofemoral arthroplasties were 
performed in 161 patients with isolated patellofemoral osteoarthritis. Patients 
were followed up regularly with clinical and radiological examinations. After 
approval from the Regional Ethics Committee (NL15032.075.06) and Institutional 
Review Board, informed consent was obtained from every patient before the final 
follow-up analysis in 2007. Thirty-five patients (41 knees) had died during follow-up; 
clinical and radiological data obtained before their deaths were included. Median 
time to demise after arthroplasty was 14.1 (range, 2.3-29.1) years. Four patients 
with 4 patellofemoral replacements (2%) were lost to follow-up. Therefore, 
information on surgical outcomes was complete for 157 patients (181 knees). 
Median time to follow-up was 13.3 (range, 2.0-30.6) years. Demographic data are 
presented in Table 1.
Table 1 Patient characteristics.
Characteristic
Number of patients (knees) 157 (181)
Side (right : left) 92 : 89
Age at operation 52 (14) years
Sex (female : male) 98 : 59
Height 172 (8) cm
Weight 82 (15) kg
Body mass index 27.8 (4.7) kg/m2
Number of previous surgeries
Realignment procedures 25
Patelloplasties 109
Meniscectomies 24
Other 19
Continuous values are given as the mean with standard deviation in parentheses.
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Patellofemoral arthroplasty was performed by 3 similarly experienced surgeons 
at our Institution using a currently commercially available Richards type II 
prosthesis (Smith & Nephew). After a medial parapatellar or midline incision and 
medial arthrotomy, the patellofemoral joint and femorotibial compartment were 
assessed for degenerative disease. No degenerative changes in femorotibial 
compartments with articular cartilage grade 2 or higher were found in any patient. 
A template was used to determine size (short or long) and optimal placement of 
the femoral component in the trochlear groove. Alignment of the femoral 
component in the sagittal plane was assessed carefully to prevent distal 
impingement of the prosthesis against the anterior cruciate ligament. No alignment 
guide for rotation in the coronal plane was available; thus, optimal positioning 
was determined by visual alignment of the long axis of the trial component with 
the trochlear groove. The trochlear cartilage with subchondral bone was then 
removed using a small chisel; and after a central hole for the peg was created, the 
trial component was inserted. After resection of patellar subchondral bone with 
an oscillating saw and sizing of the patellar component, a rotating trial component 
was inserted on the medial aspect of the patella with restoration of patellar 
thickness. Any bone remaining on the lateral side was then beveled to prevent 
impingement against the lateral femoral condyle or trochlear prosthesis. Stability 
(patellar tilt, subluxation) and impingement (catching) were tested over a full range 
of motion before the definitive components were cemented in place (Figure 1). 
A short trochlear component was used in all but 1 knee. Concomitant distal 
realignment was performed after insertion of the prosthesis in 5 patients. One 
patient underwent debridement of a chondral lesion on the medial femoral 
condyle; and in 1 patient, hardware from a previous realignment was removed.
Initially, direct postoperative weight bearing was restricted for 2 weeks; however, 
since 1989, we have allowed patients immediate postoperative protected weight 
bearing with crutches. All patients routinely received antithrombotic prophylaxis 
with warfarin for 8 weeks.
Immediate postoperative radiographs (anteroposterior and lateral non-weight 
bearing) were reviewed to evaluate the position of the prosthesis. During follow-up, 
radiological evaluations included 3 radiographs: anteroposterior standing, lateral 
non-weight bearing, and axial patellar. The same radiologist assessed all 
sequential radiographs to determine the existence or progression of femorotibial 
osteoarthritis and loosening or wear of the prosthesis. Radiological findings were
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Figure 1 Intraoperative photograph showing cemented Richards type II 
patellofemoral prosthesis In position.
reported using the Knee Society total knee arthroplasty roentgenographlc evaluation 
and scoring system (Ewald 1989).
To assess the primary objective, we stratified Indications for surgery Into 3 
diagnostic groups: primary Isolated patellofemoral osteoarthritis (Group I), 
posttraumatlc patellofemoral osteoarthritis after patellar fracture or direct trauma 
(Group II), and patellofemoral osteoarthritis with a previous realignment procedure 
for patellar subluxation or trochlear dysplasia (Group III). Further surgery was 
defined as any surgical procedure after the primary patellofemoral arthroplasty, 
Including conversion to patellofemoral arthroplasty or total knee arthroplasty. The 
end point for survival analysis was clinical failure of the primary arthroplasty 
resulting In conversion to total knee arthroplasty, revision to patellofemoral 
arthroplasty, or removal of the prosthesis.
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We performed descriptive analysis by calculating the means and standard 
deviations for continuous variables and frequencies for categorical variables. 
The Kaplan-Meier product-limited method was used for survival analyses. A knee 
was censored if it had not been revised by the end of the study or at death (without 
prior conversion). Survival curves with 95% confidence intervals (CIs) were computed.
Conversion rates between the three different diagnostic groups were compared 
using the Cox proportional-hazards technique with calculation of the hazard ratio 
and 95% Cl. A p-value < 0.05 was considered statistically significant. Similarly, 
the Cox proportional-hazards technique was used to compare conversion rates 
between patients 50 years or younger and patients older than 50 years at 
patellofemoral arthroplasty, between female and male patients, and between 
patients with BMI not exceeding 30 kg/m2and BMI greaterthan 30 kg/m2. Because 
a number of patients had both knees operated upon, resulting in nonindepen­
dence among observations, the Cox proportional-hazards technique was 
adjusted for clustering of observations within the same patient.
We identified 3 different failure mechanisms: conversion to total knee arthroplasty 
for progression of femorotibial osteoarthritis, revision for malposition that resulted 
in catching and instability, and revision for wear and/or loosening. Survival data 
were computed for each of these 3 end points.
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Results
No technical complications occurred during any surgery. Immediate postoperative 
radiographs confirmed adequate positioning of the prosthesis in 174 of 181 knees 
(96%; Figure 2). Radiologically visible component malposition, with the distal tip 
of the femoral component projecting into the intercondylar notch, was observed 
in 7 (4%) of 181 knees. Postoperatively, 11 knees in 10 patients (6%) required 
manipulation under anesthesia. The indication for manipulation was failure to 
achieve 90° of flexion by 6 weeks postoperation. Ninety-five further surgical 
procedures were performed on 69 knees (38%) in 67 patients (43%) during the 
follow-up period (Table 2).
Figure 2 Direct postoperative radiograph demonstrating adequate position 
of the Richards type II prosthesis. (A) Anteroposterior view.
(B) Lateral view.
At final follow-up, a 1mm radiolucency was seen in patellar zone 2 in 6 of the 137 
unrevised knees (115 patients). No femoral or patellar component had migrated. 
Degenerative changes of the femorotibial compartments were observed in 61 
knees (45%), with predominantly medial femorotibial involvement.
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Tab le 2 Further surgery performed on 181 knees after primary 
patellofemoral arthroplasty.
Further surgical procedures Number of Time to conversion
procedures (years)
Arthrotomy 14 (8%)
Arthroscopy 27 (15%)
Other 10 (6%)
Removal of prosthesis
Infection 1 (1%) 20.6
Malposition 2 (1%) 0.8 and 7.0
Conversion to
Total knee arthroplasty
Femorotibial osteoarthritis 23 (13%) 11.7 (8.0)
Patellofemoral arthroplasty
Malposition 10 (6%) 2.2 (1.8)
Loosening 4 (2%) 8.5 (8.9)
Wear 4 (2%) 7.1 (4.3)
The values In the number of procedures column are given as absolute numbers with the percentage In 
parentheses. The values In the time to conversion column are given as the mean with standard deviation 
In parentheses.
Survivorship analysis based on clinical failure of the primary arthroplasty revealed 
84% (95% Cl, 78%-90%) cumulative survival at 10 years and 69% (95% Cl, 
59%-79%) cumulative survival at 20 years (Figure 3).
Survival analysis using the Cox proportional-hazards technique demonstrated 
that primary diagnosis as an indication for patellofemoral arthroplasty did not 
significantly affect the conversion rate (Table 3).
No significant differences in rates of conversion were noted between patients 50 
years or younger and patients older than 50 years at patellofemoral arthroplasty, 
or between female and male patients. The rate of revision in obese patients (BMI 
>30 kg/m2) was higher than that in nonobese patients (Table 3).
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Time (years)
Figure 3 Kaplan-Meier curve denoting the cumulative probability of 
conversion for any reason, including 95% CIs.
The most common reasons for conversion in this series were progression of 
femorotibial osteoarthritis (13%), revision for malposition that resulted in catching 
and instability (7%), and loosening and/or wear of the patellar component (4%; 
Tab le 2). Of the 10 knees that were revised to another Richards type II patellofemoral 
arthroplasty for malposition, one had an additional revision for persistent instability 
5 months later and was converted to a total knee replacement 2 years later. One 
patient (1 knee) had recurrent patellar dislocations but did not want further 
surgery. Results in the other 8 knees were satisfactory.
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Tab le 3 Conversion rates to patellofemoral or total knee arthroplasty for 
different groups.
Covariates Number of Time to Cox proportional
conversions conversion hazards
in years
Diagnostic group p=0.35
Group I (n = 138) § 34 (25%) 8.6 (7.8)
Group II (n=22) 4 (18%) 9.7 (5.7) HR 0.7 (0.2-2.2)
Group III (n=21) 6 (29%) 8.2 (10.0) HR 1.7 (0.7-4.2)
Age p=0.65
< 50 years (n=85) § 20 (24%) 8.5 (8.5)
> 50 years (n=96) 24 (25%) 8.8 (7.3) HR 1.2 (0.6-2.1)
Sex p=0.24
Female (n=114) § 29 (25%) 7.1 (6.1)
Male (n=67) 15 (22%) 11.6 (9.8) HR 0.7 (0.3-1.3)
Body mass index p=0.02
<30 kg/m2 (n = 124) § 26 (21%) 9.4 (8.7)
> 30 kg/m2 (n = 57) 18 (32%) 7.5 (6.1) HR 2.1 (1.2-4.0)
The values In the number of conversions column are given as the absolute number with the percentage 
In parentheses. The values In the time to conversion column are given as the mean with standard 
deviation In parentheses. HR Indicates hazard ratio, with 95% CIs In parentheses. § Indicates reference 
level for hazard ratios.
Discussion
Our results demonstrate an overall revision rate of 24% using the Richards type II 
patellofemoral arthroplasty for Isolated patellofemoral osteoarthritis, with 
cumulative survivals of 84% and 69% after 10 and 20 years, respectively. This 
conversion rate Is superior to the long-term follow-up conversion rates reported In 
the literature (Cartier et al. 2005, Argenson et al. 2005). The number of knees 
requiring further surgery coincides with that reported In other series (Blazlna et al. 
1979, Kooljman et al. 2003, Board et al. 2004). A recent review reported a 
reoperatlon rate of 24% (Leadbetter et al. 2005). Extensor malalignment with
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prosthetic instability, progression of arthritis, prosthetic malposition, mechanical 
prosthetic related symptoms, and prosthetic type were most often correlated with 
revision surgery (Leadbetter et al. 2005). The number of knees requiring 
manipulation was high. Our postpatellofemoral arthroplasty rehabilitation protocol 
is similar to the protocol used after total knee arthroplasty; thus, the reason for the 
elevated manipulation rate is not clear.
This study had several limitations that should be noted. With a maximum follow-up 
of more than 30 years, the use of the same clinical scoring system for all cases 
was not feasible, which eliminated our ability to compare preoperative and 
follow-up clinical scores for the group as a whole. Furthermore, postoperative 
treatment protocols have changed over time; and rehabilitation regimens have 
become more aggressive. Another limitation is that 3 different surgeons performed 
the surgeries; however, the surgical procedure was standardized; and all of 
the surgeons who participated in the study were similarly experienced. Finally,
4 patients were lost to follow-up and were not included in the survival analysis; no 
worst-case scenario was used in reporting the results. We are unable to rule out 
the possibility that these patients had a revision in another hospital.
Several investigators have emphasized the importance of proper patient selection 
for patellofemoral arthroplasty (Leadbetter et al. 2005). Clear contraindications 
have been reported; however, the optimal indication for patellofemoral arthroplasty 
is less clear. Reported short-term and midterm results vary; and although most 
clinical researchers describe better results in patients with trochlear dysplasia or 
surgically corrected maltracking or instability (Arciero and Toomey 1988, Argenson 
et al. 1995, Argenson et al. 2005), some found better results in patients with 
posttraumatic patellofemoral osteoarthritis (Argenson et al. 1995). Outcomes of 
arthroplasty for primary isolated patellofemoral osteoarthritis were the least 
favorable. After a median of 13.3 years of follow-up in 181 patellofemoral 
arthroplasties, we found no differences in outcomes among the 3 different 
indications using the Cox proportional-hazards technique. Furthermore, the 
results from the current study demonstrate that patients who were younger than 
50 years at the primary procedure do not have a higher risk of revision for any 
reason than do patients who were older than 50 years. This demonstrates that the 
ongoing concerns regarding survival after total knee arthroplasty in younger 
patients do not apply to patellofemoral arthroplasty (Harrysson et al. 2004, Gioe 
et al. 2007). A number of studies suggest higher revision rates after total knee
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arthroplasty In obese patients (Amin et al. 2006). Indeed, we found a significantly 
higher risk of any type of conversion In obese patients (BMI > 30 kg/m2).
Several “failure scenarios” contributed to the overall revision rate of 24% In the 
current study. Major sources of failure described In the literature are progression 
of femorotlblal osteoarthritis, malposition of the prosthesis, and loosening and/ 
or wear.
In our series, progression of femorotlblal osteoarthritis accounted for more than 
half of the revisions. Several knees were converted to total knee arthroplasty for 
early progression of femorotlblal osteoarthritis. Although these patients could 
have been misdiagnosed with Isolated patellofemoral osteoarthritis, no significant 
degenerative changes were found on visual assessment of the femorotlblal 
compartments at primary patellofemoral arthroplasty.
Malposition of the prosthesis with resultant Instability or Impingement of the 
prosthesis was also an Important cause for revision In our study. These prosthetic- 
related failures have been described by several authors as patellar maltracklng or 
Implant malalignment. Reported causes Include surgical prosthetic malalignment 
of the femoral component (flexion, rotation), prosthetic malalignment of the 
patellar component (rotation, lateral placement), uncorrected malalignment of the 
extensor apparatus, soft tissue Imbalance, and design characteristics of the 
patellofemoral prosthesis. Some authors have reported a higher percentage of 
concomitant procedures addressing malalignment during Implantation of the 
patellofemoral prosthesis, which Is In sharp contrast to our series and may explain 
our higher early rate of revision for malposition. One author reported concomitant 
realignment procedures In 85% of cases (Cartier et al. 1990). High revision rates 
for maltracklng with the Richards type II prosthesis have been reported by several 
authors (Blazlna et al. 1979, Arclero and Toomey 1988, de Winter et al. 2001). 
The Richards type II prosthesis has a deep constraining trochlear groove 
(Figure 4); this geometric property could have Influenced patellar tracking and 
contributed to the number of failures ascribed to malposition In our series. Lonner 
has stated that the Implant’s geometry should allow It to be Implanted flush with 
the femoral cortex proxlmally (Lonner 2007); however, this Is not possible with the 
Richards type II femoral component, which behaves more like an onlay prosthesis 
(Figure 2). Given the fact that the short version of the femoral component was 
used In all but 1 knee, the lack of sizing options could also have contributed to the
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relatively high rate of revision due to malposition (Lonner 2004). In revision 
arthroplasty for malposition, the position of the trochlear component relative to 
the trochlear groove was not changed. To eliminate catching of the patellar 
component on the proximal extension of the prosthesis or maltracking on initiation 
of flexion, more bone was resected proximally to ensure a flush anatomical 
transition of the trochlear component to the anterior femoral cortex. Similar 
observations have been described by Lonner (Lonner 2004). Because the results 
of these revisions to patellofemoral arthroplasty were satisfactory in the majority 
of patients, we do not routinely perform conversion to total knee arthroplasty in 
cases of malposition.
Recently, the use of more contemporary trochlear designs has helped decrease 
the incidence of patellofemoral complications (Lonner 2004, Sisto and Sarin
2006). Newer designs with more sizing options and improved geometric properties 
should provide a better fit to the trochlea and distal femur.
Figure 4 Photograph of the Richards type II patellofemoral prosthesis.
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In our series, loosening and/or wear of one or both components as a basis for 
revision was observed In 8 (4%) knees. Loosening of the cemented trochlear 
component was not observed, which Is In accordance with the literature; cases of 
trochlear component loosening have been reported for cementless femoral 
component designs (Argenson et al. 2005).
Conclusions
Long-term outcomes of patellofemoral arthroplasty using the Richards type II 
prosthesis are not affected by primary diagnosis, sex, or age at patellofemoral 
arthroplasty. The large number of patellofemoral complications that necessitate 
revision for malposition could have been due to the constraining geometric 
properties of the Richards type II prosthesis.
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Conversion of patellofemoral arthroplasty 
to total knee arthroplasty: A matched case-control 
study of 13 patients
van Jonbergen H P W, Werkman D M, van Kampen A.
Acta Orthop 2009; 80: 62-6.
Resu lts of conversion to total knee arthroplasty
Abstract
Background and purpose: The long-term outcome of patellofemoral arthroplasty 
Is related to progression of femorotlblal osteoarthritis with need for conversion to 
total knee arthroplasty. We Investigated whether prior patellofemoral arthroplasty 
compromises the results of total knee arthroplasty.
Methods: 13 patients who had had 14 Richards type II patellofemoral arthroplasties 
converted to total knee arthroplasty because of femorotlblal osteoarthritis, were 
Individually matched to a control group of 13 patients with 14 primary total knee 
arthroplasties. The mean follow-up times for the patients and the control group 
were 5.7 (2-13) years and 5.2 (2-13) years, respectively. Clinical outcome was 
assessed using Knee Society score (KSS), WOMAC score, range of motion, and 
complications.
Results: KSS and WOMAC scores were similar In the two groups (KSS In patient 
and control groups: 82 and 86 (p = 0.6); KSS function: 76 and 88 (p = 0.5); WOMAC 
score: 33 and 21 (p=0.1)). Within 6 months after conversion, 3 knees had to be 
manipulated under anesthesia for limited motion. No patients In the control group 
required manipulation under anesthesia.
Interpretation: Patellofemoral arthroplasty appears not to have a negative effect 
on the outcome of later total knee arthroplasty.
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Introduction
Patellofemoral arthroplasty Is a treatment alternative for Isolated patellofemoral 
osteoarthritis. The long-term outcome Is related to malposition of the prosthesis, 
the progression or development of femorotlblal osteoarthritis, and - to a lesser 
extent - wear and/or loosening of the patellar component. Several reports have 
described the progression of symptomatic femorotlblal osteoarthritis as an 
Important reason for conversion to total knee arthroplasty, with an overall revision 
rate of between 4% and 28% (Argenson et al. 2005, Leadbetter et al. 2005, Nlcol 
et al. 2006, Ackroyd et al. 2007).
With the renewed Interest In patellofemoral arthroplasty, more conversion to total 
knee arthroplasty due to progression of femorotlblal osteoarthritis may be 
anticipated. Only one paper has reviewed the results of revision of a failed 
patellofemoral arthroplasty to a total knee arthroplasty (Lonner et al. 2006). No 
technical difficulties were observed, and clinical outcome as assessed by the 
Knee Society score (KSS) Improved after revision. However, whether or not these 
results compare favorably with the results obtained after primary total knee 
arthroplasty Is unknown.
We therefore performed a retrospective case-control study to compare the 
outcome of patients with a patellofemoral arthroplasty converted to a total knee 
arthroplasty with that of a matched group of patients with a primary total knee 
arthroplasty for femorotlblal osteoarthritis.
Patients and methods
Patient selection
Patellofemoral arthroplasty has been performed at our Institution since 1976. 
The entire cohort of 172 patients with 196 patellofemoral arthroplasties had a 
regular follow-up with clinical and radiographic examinations every 1 or 2 years.
Between October 1987 and March 2007, 23 Richards type II patellofemoral 
arthroplasties (Smith and Nephew, Memphis, TN) were revised to total knee 
arthroplasty In 22 patients (17 women) because of development of painful 
femorotlblal osteoarthritis. No conversions had been done before 1987.
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Seven patients had died since conversion (of causes unrelated to surgery), and 
only patients with at least 2 years of follow-up were included. The index group 
thus consisted of 14 revision total knee arthroplasties in 13 patients (10 women), 
with revision surgery performed between 1993 and 2005. The study was performed 
with retrospective data collection and review. The study protocol was approved 
by the institutional Review Board (NL22632.075.0818, March 2008). A control 
group of 14 primary total knee arthroplasties in 13 patients was selected from the 
cohort of primary total knee arthroplasties performed at our institution during the 
same time period. The underlying diagnosis was primary osteoarthritis in all 
patients. Only patients with at least 2 years of follow-up were included.
To prevent cohort disparity, each case was individually matched on the basis of 
7 attributes: sex, age at time of total knee arthroplasty (± 5 years), date of surgery 
(± 1 year), type of total knee prosthesis, duration of follow-up (± 1 year), body 
mass index (± 2), and radiographic grade of osteoarthritis (Table 1). No matches 
were made for type and number of previous procedures. The matching process 
was performed blind to the clinical outcome.
Informed consent was obtained from all patients.
Clinical evaluation
Patients in both groups had regular follow-up with clinical and radiographic 
examinations every 1 or 2 years after surgery. All patients completed the Dutch 
version of the WOMAC 3.1 Osteoarthritis Index, range of motion was registered, 
and the KSS was used for outcome assessment (Insall et al. 1989).
Radiographic evaluation
Preoperative radiographs were assessed by a radiologist for femorotibial 
osteoarthritis using the Kellgren and the Ahlback grading systems (Kellgren and 
Lawrence 1957, Ahlback 1968). Immediate postoperative radiographs (antero­
posterior and lateral non-weight bearing) were evaluated to assess the position of 
the prosthesis. During follow-up, the radiographic examination consisted of 
2 radiographs (anteroposterior standing and lateral non-weight bearing), and all 
sequential radiographs were assessed by a radiologist to determine loosening 
or wear of the prosthesis.
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Statistics
No power analysis was performed prior to this study, as all patients who had a 
conversion from patellofemoral to total knee arthrop lasty at our institution were 
included. The Fisher exact probability test was used for categorical data, and the 
W ilcoxon signed ranks test was used to investigate differences in continuous data 
between groups. All p-values less than 0.05 were considered significant.
Results
Matching
No statistically significant d ifferences w ith respect to age, preoperative grade of 
osteoarthritis, duration of follow-up, or body mass index were found between the 
two groups (Table 1).
Tab le 1 Demographic and radiographic data for 14 knees w ith a
patellofemoral arthrop lasty prior to conversion to total knee 
arthroplasties (index group) and 14 knees w ith primary total knee 
arthroplasties (control group).
Index Control p-value
Sex (female : male) 10 : 3 10 : 3
Number of knees 14 14
Age at time of total knee arthroplasty, 
years (range)
67 (50-77) 68 (51-76) 0.7
Follow-up, years (range) 5.7 (2.0-13) 5.2 (2.1-13) 0.1
Body mass index, kg/m2 (range) 29 (22-35) 29 (23-34) 0.4
Kellgren grade 0.3
1 0 0
2 6 8
3 6 2
4 2 4
Ahlback grade 0.6
1 11 12
2 2 0
3 1 2
4 0 0
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Previous patellofemoral arthroplasty
The mean age at patellofemoral arthroplasty was 56 (35-72) years. The Richards 
type II patellofemoral prosthesis was used In all patients. Further surgery after 
patellofemoral arthroplasty was performed In 9 knees and Included 16 procedures 
(2 knees were manipulated under anesthesia; arthrotomy for painful bony 
Impingement or persistent pain was done In 3 knees; 9 arthroscopies were 
performed (femorotlblal debridement, meniscectomy, diagnostic); and 1 knee 
had a proximal tlblal osteotomy with subsequent hardware removal). The 
patellofemoral prostheses had been In place before conversion to total knee 
arthroplasty for an average of 11 (1.2-27) years.
Surgical procedure
In both groups, total knee arthroplasty was performed by several surgeons with 
similar experience. Before 1999, the posterior-stabilized Insall-Bursteln total knee 
prosthesis was used (Insall-Bursteln; Zimmer, Warsaw, IN), and from 1999 
onwards a NexGen posterior-stabilized total knee prosthesis was used (NexGen; 
Zimmer). In each group, 3 Insall-Bursteln prostheses and 11 NexGen prostheses 
were used. Operative records were available for all patients.
At conversion, both the femoral and patellar component were removed In all 
cases (Figures 1 and 2). The distal femur was prepared using standard cutting 
blocks with resection of the soft cancellous bone directly beneath the femoral 
component (Figure 3). Patellarthlckness was restored using the standard patellar 
component for total knee arthroplasty. After preparation of the proximal tibia and 
Insertion of trial components, patellofemoral stability was tested through a full 
range of motion before the definitive components were cemented In place. 
Condylar support for the femoral component was adequate In all cases; no 
additional metal augmentation was required for any of the knees. Identical surgical 
procedures and cutting blocks were used for primary total knee arthroplasty In 
the control group. In all cases, patellar resurfacing was performed using the 
standard patellar component for total knee arthroplasty.
Radiographs taken Immediately postoperatlvely showed adequate positioning of 
the prosthesis In all 28 knees. Patients were allowed Immediate protected weight 
bearing with crutches. All patients routinely received coumarlne prophylactlcally 
for 8 weeks. Data for operative time and blood loss were Incomplete and were 
therefore not Included In the analysis.
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Figure 3 After preparation of distal femur and proximal tibia using 
the standard cutting blocks.
Complications and further surgery
Within 6 months of conversion from patellofemoral arthroplasty to total knee 
arthroplasty, 3 knees (in 3 patients) had to be manipulated under anesthesia for 
failure to achieve 90 degrees of flexion by 6 weeks postoperatively. In 2 of these 
patients, manipulation had also been necessary after the previous patellofemoral 
arthroplasty. For the 3 patients requiring manipulation, the mean time between 
patellofemoral arthroplasty and conversion was 15 (13-17) years. The patients 
had had an average of 4 previous knee operations before conversion and achieved 
a mean preoperative flexion of 98 (85-120) degrees.
One patient (with 3 previous procedures before conversion, including patello­
femoral arthroplasty, proximal tibial osteotomy, and subsequent hardware removal) 
had signs of infection of the prosthesis within this time period, and received 
adequate operative and antibiotic treatment. To date, he has no clinical signs of 
infection of the total knee prosthesis. No patients had patellofemoral-related 
complications.
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In the control group, no further surgery or manipulation under anesthesia within 
this time period was required or performed, and no complications were 
observed.
Clinical outcome
The functional outcome using KSS, WOMAC scores, and range of motion were 
similar In both groups (Table 2). Additional analysis of subscores of the KSS 
(pain, range of motion, and stability) and WOMAC (pain, stiffness, and function) 
showed no statistically significant differences between the Index and control 
groups. Preoperative KSS and WOMAC scores were not available for the entire 
group, so comparison of Improvement between the groups was not possible.
Tab le 2 Clinical outcome after total knee arthroplasty. Values are mean (SD).
Index Control p-value
KSS (max. 100) 82 (19) 86 (10) 0.6
KSS function (max. 100) 76 (31) 88 (10) 0.5
WOMAC (max. 96) 33 (23) 21 (16) 0.1
Preoperative flexion (degrees) 108 (14) 110 (12) 0.7
Postoperative flexion (degrees) 117 (13) 116 (11) 0.9
Radiographic outcome
At final follow-up, none of the knees showed signs of radiographic loosening and/ 
or wear.
Discussion
Our findings suggest that patellofemoral arthroplasty has no negative effect on 
the outcome of later total knee arthroplasty.
Although no statistically significant differences In KSS and WOMAC scores 
between the groups were found, the high number of manipulations In the 
patellofemoral conversion group may be an Important observation. Recently, 
Lonner et al. (2006) assessed the conversion of patellofemoral knee replacement 
to total knee arthroplasty In 12 patients and found that 2 of the patients required
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manipulation under anesthesia 6 weeks after conversion. In our complete cohort 
of patients with primary patellofemoral arthroplasty, 12 of 196 knees (6%) in 11 of 
172 patients had to be manipulated under anesthesia within 6 months of 
arthroplasty. Several other studies have noted a need for manipulation under 
anesthesia for stiffness within 6 months of patellofemoral arthroplasty, with 
reported incidences ranging from 3% to 14% (Arciero and Toomey 1988, Argenson 
et al. 1995, de Winter et al. 2001, Ackroyd and Chir 2005). The reasons underlying 
the need for manipulation may be complex and possibly related to the primary 
patellofemoral disease process and surgical treatment before patellofemoral 
arthroplasty. The reported prevalence of stiffness after primary total knee 
arthroplasty varies from 1% to 5%, although it is notable that a commonly used 
definition of stiffness following knee arthroplasty is lacking (Kim et al. 2004, 
Yercan et al. 2006, Keating et al. 2007). A history of previous knee surgery and the 
preoperative range of motion are important predictors of the range of motion after 
total knee arthroplasty.
Our study has several limitations. Although progression or development of 
femorotibial osteoarthritis is an important reason for conversion to total knee 
arthroplasty, large populations need to be tracked for long periods of time to 
observe disease development. Also, follow-up after conversion to total knee 
arthroplasty should be extended to several years to reliably evaluate the results of 
conversion. Thus, a case-control study was designed using a cohort of patients 
with conversion to total knee arthroplasty. With the small number of patients 
available in our study, no statistically significant differences in clinical outcome 
using KSS and WOMAC scores were found. Furthermore, more discriminatory 
knee scoring systems may be necessary (Paxton and Fithian 2005). Potential 
differences in improvement between the two groups were not evaluated, as 
preoperative KSS and WOMAC scores for the entire group were not available.
To date, only 1 paper has reported the results of revision of failed patellofemoral 
arthroplasty to a total knee arthroplasty (Lonner et al. 2006). Conversion of 
patellofemoral arthroplasty to a NexGen Legacy posterior-stabilized total knee 
arthroplasty was performed in 12 patients for patellar maltracking or degenerative 
joint disease. At a mean follow-up of 3 (2-5) years, all patients had higher Knee 
Society clinical and functional scores. No technical difficulties were encountered 
during revision. No patellar components were revised, since the femoral 
component was accommodating to the original dome-shaped all-polyethylene
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patellar components of the Lublnus, Autocentrlc, Low-Contact Stress or Avon 
patellofemoral prostheses. At our Institution, however, the patellar component 
was revised In all cases. The Richards type II all-polyethylene patellar prosthesis 
has a long mldllne central ridge (Figure 1). Retaining the patellar prosthesis could 
have resulted In maltracklng or Increased wear of the polyethylene; thus, some 
authors have suggested that patellofemoral arthroplasty should use a universal 
patellar component that Is compatible with total knee systems, thus obviating the 
need for revision of the patella (Argenson et al. 2005).
We did not experience technical problems during conversion. Removal of the 
trochlear component proved to be straightforward, without any substantial loss of 
bone. Use of the standard total knee replacement cutting blocks resulted In an 
optimally prepared distal femur, and therefore metal augmentation was not 
required In any of the patients. This was also observed by Lonner et al. (2006), 
who noted that condylar support In each knee was uncompromised.
59

Distal femoral bone mineral density decreases 
following patellofemoral arthroplasty: 1-year follow-up 
study of 14 patients
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Distal femoral bone m ineral density after patellofem oral arthroplasty
Abstract
Background: The bone mineral density (BMD) of the distal femur decreases by 
16-36% within one year after total knee arthroplasty (TKA) because of the femoral 
component’s stress-shielding effect. The aim of this prospective study was to 
determine the quantitative change from the baseline BMD in the distal femur 
1 year after patellofemoral arthroplasty using dual-energy X-ray absorptiometry 
(DXA).
Methods: Between December2007 and December2008, 14 patients had patello­
femoral arthroplasty for isolated patellofemoral osteoarthritis. Distal femoral BMD 
was assessed using DXA in 2 regions of interest (ROI) on the lateral view 2 weeks 
before and 12 months after patellofemoral arthroplasty. The contra-lateral knee 
was used as a control, with BMD measurements performed in identical ROIs. 
Results: The mean change from baseline BMD in the operated knees after 1 year 
was -0.169 g/cm2 (95% Cl: -0.293 to -0.046 g/cm2) behind the anterior flange 
(-15%), and -0.076 g/cm2 (95% Cl: -0.177 to 0.024 g/cm2) in the supracondylar 
area 1 cm above the prosthesis (-8%) (p = 0.01 and p = 0.13, respectively). 
The mean change from baseline BMD in the non-operated knees after 1 year was 
0.016 g/cm2 (95% Cl: -0.152 to 0.185 g/cm2) in the anterior ROI (2%), and 0.023 g/cm2 
(95% Cl: -0.135 to 0.180 g/cm2) in the supracondylar area (2%) (p = 0.83, and 
p = 0.76, respectively).
Conclusions: Our findings suggest that patellofemoral arthroplasty results in a 
statistically significant decrease in BMD behind the anterior flange.
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Introduction
After total knee arthroplasty (TKA), the bone mineral density (BMD) of the distal 
femur decreases by 16-36% within one year because of the femoral component’s 
stress-shielding effect (Liu et al. 1995, Petersen et al. 1995, Karbowskl et al. 1999, 
Splttlehouse et al. 1999, van Loon et al. 2001, Solnlnvaara et al. 2004, Abu-Rajab 
et al. 2006). Although the femoral component In patellofemoral arthroplasty Is 
smaller than In TKA, the mechanical loading, and consequently the stress 
distribution of the distal femoral bone, Is altered compared with the physiological 
situation. This can lead to bone remodelling, resulting In decreased BMD behind 
the anterior flange of the femoral component. In TKA, bone loss In the distal 
anterior femur can lead to supracondylar fractures or loosening of the Implant, 
and may Induce difficulties during revision arthroplasty (van Loon et al. 1999, 
Hernlgou et al. 2006). Since patellofemoral arthroplasty Is typically used In 
younger patients, conversion to TKA after painful femorotlblal osteoarthritis 
develops will eventually be performed In a relatively large proportion of patients 
(van Jonbergen et al. 2010d). Although the clinical outcome of TKA done later 
does not appear to be Influenced by prior patellofemoral arthroplasty (van 
Jonbergen et al. 2009), the results of such a revision may, however, be 
compromised by loss of bone stock.
To date, no clinical studies have addressed the possible decrease In distal femoral 
BMD as a parameter of bone remodelling following patellofemoral arthroplasty. 
We hypothesized that because of the relative small size there Is no significant 
stress-shielding effect behind the femoral component of a patellofemoral 
prosthesis resulting In a decrease In BMD In the distal femur. The primary objective 
was, therefore, to determine the change from baseline In the BMD behind the 
anterior flange 1 year after patellofemoral arthroplasty using dual-energy X-ray 
absorptiometry (DXA).
Methods
In 2007, we Initiated a prospective study to Investigate the distal femoral BMD 
using DXA In patients undergoing patellofemoral arthroplasty. All patients who 
were planned for patellofemoral arthroplasty for Isolated patellofemoral 
osteoarthritis at Deventer Hospital, Deventer, The Netherlands, were evaluated for
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inclusion in the study. Patients with known rheumatic, renal, hepatic, or gastroin­
testinal disease, and patients using medication that interferes with mineral 
metabolism (i.e. treatment for osteoporosis or long-term steroid therapy) were 
excluded from the study. Additionally, patients with a previous TKA or patellofemoral 
arthroplasty of the contra-lateral knee were excluded. The study was approved by 
the Regional Ethics Committee (NL16145.075.07, December2007) and Institutional 
Review Board.
Sample size was calculated using estimates of mean femoral BMD and standard 
deviation (SD) behind the anterior flange after TKA (Abu-Rajab et al. 2006). The 
reported mean BMD behind the anterior flange of a total knee prosthesis in the 
replaced knee was 0.94 g/cm 2 (0.31), and 1.25 g/cm 2 (0.30) in the contra-lateral, 
non-replaced knee (Abu-Rajab et al. 2006). A group sample size of 13 patients 
achieves 95% power to detect a difference of 0.31 g/cm2 between the null 
hypothesis that both group means are 1.25 g/cm 2, and the alternative hypothesis 
that the mean of group 2 (replaced knee) is 0.94 g /cm 2 with known group SDs of 
0.31 g/cm 2 and 0.30 g/cm 2 and with a significance level (alpha) of 0.05 using a 
two-tailed paired t-test (PASS 2008, NCSS software, Kaysville, Utah).
Between December 2007 and December 2008, 2 orthopedic surgeons who 
performed patellofemoral arthroplasty at Deventer Hospital recruited 14 patients. 
All patients provided written informed consent. All eligible patients were 
preoperatively assessed by 1 of the 2 participating orthopedic surgeons, who 
completed the Knee Society Knee Score (KSKS) and the Knee Society Functional 
Score (KSFS). The Dutch version of the Western Ontario and McMaster Universities 
Osteoarthritis Index 3.1 (WOMAC) was completed by all patients. Measurement of 
the BMD in the distal femur was performed using DXA in the lateral view (GE 
Lunar Prodigy system, General Electrics, O ldelft Benelux B.V., Delft/Veenendaal, 
The Netherlands) 2 weeks before patellofemoral arthroplasty and 12 months after 
arthroplasty. Measurements of a calibration phantom were performed each day 
before scanning the patients. All measurements were made by an independent 
radiographic technician. Both the scanning procedure and positioning of the 
patients and knees were standardized, with the patient in the lateral decubitus 
position and the knee flexed 15-30 degrees to obtain a true lateral scan. Two 
regions of interest (ROI) were selected; one in the distal anterior area just behind 
the anterior flange of the prosthesis (centered between the tip of the fixation peg 
and the proximal end of the prosthesis) (ROI 1), and the other more proximally, in
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the supracondylar area 1 cm superior to the anterior flange of the femoral 
component (ROI 2) (Figure 1). ROI 2 was selected as a reference ROI above the 
prosthesis, where stress-shielding was assumed to be negligible. The measured 
area of each ROI was 1 x 1cm. The contra-lateral, non-operated knee was used 
as a control, with BMD measurements In Identical ROI s. We employed knee-specific 
software In all cases.
Figure 1 Location of regions of Interest 
(ROI) on a lateral radiograph 
of a right knee.
Two similarly experienced surgeons at our Institution performed patellofemoral 
arthroplasty with the currently commercially available Richards type II prosthesis 
(Smith & Nephew Inc., Memphis, Tennessee). Surgery was performed under 
pneumatic tourniquet control and antibiotic prophylaxis using Intravenous 
Cefazollne 1 g, 3 times dally, for the first 24 hours with the first dose administered 
30 minutes before application of the tourniquet. All operations were performed In 
an Identical manner according to the manufacturers’ Instruction, as described 
elsewhere (van Jonbergen et al. 2010d). No Intramedullary guiding rod was used 
during surgery. All 14 patients received the same postoperative treatment. We
65
Distal femoral bone m ineral density after patellofem oral arthroplasty
allowed patients protected weight bearing with crutches Immediate after surgery, 
and full unrestricted weight bearing was allowed 6 weeks after surgery. All patients 
routinely received antithrombotic prophylaxis with a low-molecular-welght heparin 
(Fragmln) for 6 weeks.
All patients had regular clinical follow-ups at 2 and 8 weeks to evaluate wound 
healing and rehabilitation, DXA was not performed at these follow-up visits. At the
1 -year follow-up, patients were clinically assessed using the KSKS and KSFS, and 
were asked to complete the WOMAC questionnaire. During follow-up, the 
radiological examinations consisted of 2 radiographs (anteroposterior standing 
and lateral non-weight bearing) performed 6 weeks and one year post surgery 
(Figure 2). Radiological findings were reported using the Knee Society total knee 
arthroplasty roentgenographlc evaluation and scoring system (Ewald 1989).
Figure 2 Anteroposterior (A) and lateral (B) radiographs of a right knee 
one year after patellofemoral arthroplasty.
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All pertinent data were entered In a spreadsheet program and analyzed using 
PASW Statistics 18 software (SPSS Inc, Chicago, Illinois). We performed descriptive 
analysis using the mean and standard deviation for continuous variables, and 
frequencies for categorical variables. The 95% confidence Intervals (Cl) were 
calculated for the absolute changes In BMD from baseline. The two-tailed paired 
t test was used to analyze for differences In preoperative and postoperative BMD. 
A linear regression model was used to evaluate for Influence of BMI, age, and sex 
on change In BMD from baseline. A p-value of less than 0.05 was considered 
significant In all the tests.
Results
Between December 2007 and December 2008, 14 patients had unilateral patello- 
femoral arthroplasty, receiving the Richards type II patellofemoral prosthesis. 
All 14 patients were available for the one year follow-up. The patient’s demographic 
data are presented In Table 1.
Table 1 Patient characteristics.
Characteristic
Number of knees 14
Side (right: left) 7 : 7
Mean (SD) age at surgery 53 (10) years
Sex (female: male) 9 : 5
Mean (SD) Height 175 (5) cm
Mean (SD) Weight 87 (13) kg
Mean (SD) body mass index 28 (4) kg/m2
C ontinuous values are given as the mean w ith s tandard deviation in parentheses.
Mean KSKS Improved from 61 (range, 50 to 78) preoperatlvely to 88 (range, 60 to 
100) one year after surgery (p<0.001). Mean KSFS Improved from 65 (range, 50 
to 80) preoperatlvely to 86 (range, 50 to 100) one year after surgery (p = 0.004). 
The mean preoperative WOMAC scores Improved from 50 (range, 22 to 69) to 23 
(range, 4 to 39) one year after surgery (p<0.001). No com plications were noted
67
Distal femoral bone m ineral density after patellofem oral arthroplasty
from the surgical procedure within the study period. The 1-year radiographic 
follow-up showed that all prostheses were in good alignment w ithout radiolucent 
lines or osteolysis.
Results of the BMD measurements are summarized in Table 2. In the operated 
knees, there was a 15% decrease in mean BMD at 12 months in ROI 1 (p = 0.01), 
and an 8% decrease in ROI 2 (p = 0.13). In the non-operated knees, there was a 
2% increase in the mean BMD at 12 months in both ROI 1 and ROI 2 (p = 0.83 and 
p = 0.76, respectively).
Table 2 Bone mineral density (BMD, g/cm 2) measured in the distal femur
before (t=0) and 12 months after (t=12) patellofemoral arthroplasty.
BMD BMD Change from 95% Cl for p-value
(t = 0) (t = 12) baseline the difference
Operated knee
ROI 1 1.106 0.937 -0.169 -0.293 0.01
(0.229) (0.362) (0.204) to -0.046
ROI 2 0.981 0.905 -0.076 -0.177 0.13
(0.272) (0.261) (0.167) to 0.024
Non-operated knee
ROI 1 1.099 1.115 0.016 -0.152 0.83
(0.266) (0.315) (0.251) to 0.185
ROI 2 0.930 0.952 0.023 -0.135 0.76
(0.175) (0.266) (0.234) to 0.180
C ontinuous va lues are given as the mean w ith  s tandard  devia tion in parentheses. 
Cl, confidence Interval; ROI, region of Interest.
Regression analysis of the change from baseline BMD for both regions of interest 
against BMI (regression coefficient = 0.017, p=0.3), age (regression coefficient = 
0.002, p = 0.8), and sex (regression coefficient = -0.063, p = 0.6) demonstrated 
no significant relationships.
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Discussion
The results of our prospective, 1-year DXA study demonstrate a statistically 
significant 15% decrease In BMD behind the anterior flange of the femoral 
component during the first year after patellofemoral arthroplasty. To our knowledge, 
there has been no previous study that attempted to use DXA measurements to 
evaluate changes In the distal femoral BMD after patellofemoral arthroplasty. 
Several Investigators reported the results of BMD measurements after TKA and 
demonstrated perlprosthetlc bone loss of up to 36% adjacent to the Implants 
(Petersen et al. 1995, Liu et al. 1995, Karbowskl et al. 1999, Splttlehouse et al. 
1999, van Loon et al. 2001, Solnlnvaara et al. 2004, Abu-Rajab et al. 2006). 
The general BMD as measured In hip and spine, or the BMD In the contra-lateral 
knee, did not change after arthroplasty (Karbowskl et al. 1999, van Loon et al.
2001, Abu-Rajab et al. 2006).
Flnlte-element models were used to determine whether patterns of bone resorption 
behind the femoral component In TKA could be explained by strain-adaptive bone 
remodelling (Tlssakht et al. 1996, van Lenthe et al. 1997). With a bonded femoral 
component, the predicted long-term bone loss would occur at the most distal part 
of the femur and behind the anterior part of the prosthesis (van Lenthe et al. 1997). 
These findings are In agreement with the results of clinical DXA studies, which 
observed loss of BMD behind the anterior flange of the femoral component In TKA 
(Liu et al. 1995, Petersen et al. 1995, Karbowskl et al. 1999, Splttlehouse et al. 1999, 
van Loon et al. 2001, Solnlnvaara et al. 2004, Abu-Rajab et al. 2006). Our results 
show that comparable distal femoral bone loss occurs following patellofemoral 
arthroplasty. This suggests that the stress-shielding effect Is similar to that which 
occurs after TKA, even with the smaller femoral component of the patellofemoral 
prosthesis (Figure 2). However, the clinical results do not seem to be compromised 
by the observed loss of bone. In a recent study, the long-term outcomes of the 
Richards type II patellofemoral arthroplasty were reported (van Jonbergen et al. 
201 Od). The most common reasons for conversion In this series were progression 
of femorotlblal osteoarthritis and revision for malposltlonlng that resulted In catching 
and Instability. Loosening of the femoral component was not observed, which Is In 
accordance with the literature. Furthermore, the clinical outcome of later TKA does 
not appear to be Influenced by prior patellofemoral arthroplasty (Lonner et al. 2006, 
van Jonbergen et al. 2009). No technical difficulties were experienced during 
conversion, and the condylar support In each knee was uncompromised.
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The observed decrease in the BMD in the supracondylar reference ROI 2 was not 
statistically significant. Other Investigators demonstrated an 8% decrease In the 
BMD In this diaphyseal ROI at 1 year after total knee arthroplasty (van Loon et al.
2001, Solnlnvaara et al. 2004). Solnlnvaara et al. suggested that this less 
pronounced bone loss represented both operation-related and postoperative 
Immobilization-Induced bone loss, because age-related bone loss Is minor 
(Solnlnvaara et al. 2004). However, physical activity had Improved In our patients, 
as demonstrated by the Improvement In KSFS and WOMAC scores.
The current study has some limitations that should be noted. Follow-up examinations 
were performed at 1 year after surgery. With TKA, several Investigators report that 
no additional remodelling occurs after 6-12 months (Splttlehouse et al. 1999, 
Karbowskl et al. 1999, van Loon et al. 2001, Solnlnvaara et al. 2004), while others 
stated that loss of BMD stabilizes within 2 years (Cameron and Cameron 1987, 
Abu-Rajab et al. 2006). Finite element models predict that bone resorption may 
continue after 2 years (van Lenthe et al. 1997). Thus, It Is possible that a further 
decrease In BMD occurs In our patients. Another limitation Is that we performed 
no precision measurements In our relatively small series. Therefore, we assumed 
a precision similar to those reported by others using the same Lunar Prodigy 
system, albeit with possible software differences. The reported precision for BMD 
measurements on the lateral view of the anterior femur ranges from 1.3% to 3.6% 
(Liu et al. 1995, Petersen et al. 1995, Trevlsan et al. 1998, Solnlnvaara et al. 2000, 
van Loon et al. 2001). Because of the relatively small size of the patellofemoral 
prosthesis, the ROI behind the anterior flange was also necessarily small, which 
may have resulted In weakened precision (Solnlnvaara et al. 2000).
Although our study protocol excluded medical conditions that could have affected 
the BMD, It Is possible that other conditions may have existed that Influenced the 
results. None of the patients had a severe medical disability that limited the ability 
to walk, or had a disabling disease Involving other joints of the lower extremities. 
We did not assess the amount of physical activity at one-year follow-up and were 
therefore not able to evaluate for a relationship with change from baseline BMD.
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Conclusions
Our findings suggest that Richards type II patellofemoral arthroplasty results in a 
statistically significant decrease in BMD behind the anterior flange. Newer 
designs, such as the Journey patellofemoral prosthesis (Smith&Nephew) and the 
Zimmer Gender Solutions PFJ system, employ a broader trochlear component. In 
theory, the geometry, size, and material properties may result in different patterns 
of stress shielding. Future studies should be aimed at evaluating BMD changes 
in these newer patellofemoral prostheses.
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Dynamic finite element analysis in patellofem oral arthroplasty
Abstract
B ackground : Patellofemoral joint replacement Is a successful treatment option 
for Isolated patellofemoral osteoarthritis. However, the results of later conversion 
to total knee replacement may be compromised by perlprosthetlc bone loss. 
Clinical studies demonstrated a decrease In distal femoral bone mineral density 
after patellofemoral joint replacement. The main objective of this study was to 
evaluate the stress shielding effect of prosthetic replacement with 2 different 
patellofemoral prosthesis designs and with a total knee prosthesis.
M ethods: The following finite element models were developed: an Intact 
patellofemoral joint, a replaced patellofemoral joint with a Journey PFJ and a 
Richards II prosthesis, and total knee replacement with a Genesis II prosthesis. 
For each of these 4 finite element models, the average Von Mises stress In 2 
regions of Interest was evaluated during a squatting movement until 120° of 
flexion.
F ind ings: During deep knee flexion, In the anterior region of Interest, the average 
Von Mises stress with the Journey PFJ design was comparable to the physiological 
knee, while the Richards II design showed lower stress. The Genesis II design 
Induced the lowest stress of all models. The average Von Mises stress In the 
supracondylar region of Interest was similar for both patellofemoral prosthesis 
designs and the physiological model, with slightly lower stress for the Genesis II 
design.
In te rp re ta tion : These findings are In agreement with previous clinical studies that 
have Indicated that patellofemoral joint replacement leads to a smaller decrease 
In distal femoral bone mineral density than total knee replacement. However, 
specific design properties may result In differences In femoral stress shielding.
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Introduction
Patellofemoral joint replacement is a successful treatment option for isolated 
patellofemoral osteoarthritis (van Jonbergen et al. 2010c). The long-term outcomes 
are related to progression of femorotibial osteoarthritis and the need for conversion 
to total knee replacement (van Jonbergen et al. 2010d). Because the results of 
conversion to total knee replacement may be compromised by loss of bone 
behind the femoral component, this phenomenon needsto be prevented as much 
as possible. After total knee replacement, loss of bone occurs due to the stress 
shielding effect of the femoral component (Tissakht et al. 1996, van Lenthe et al. 
1997). Although the femoral component of a patellofemoral prosthesis is smaller 
than in total knee replacement, it is unknown whether mechanically induced 
periprosthetic bone remodelling occurs following patellofemoral joint replacement.
Measurements of the periprosthetic bone mineral density (BMD) using dual-energy 
x-ray absorptiometry (DXA) demonstrated a 15% decrease in BMD behind the 
anterior flange of the femoral component during the first year after Richards II 
patellofemoral joint replacement (van Jonbergen et al. 2010b), but it is not known 
whether this is due to stress shielding. Finite element analyses have been used 
extensively in the evaluation of prosthetic load and bone remodelling after total 
hip and knee replacement (Qian et al. 2009, Zelle et al. 2009). Some investigators 
have also used numerical models to calculate the stress distribution within the 
patellar components after patellofemoral replacement (Najarian et al. 2005, Morra 
and Greenwald 2006). However, none of these models used a dynamically loaded 
distal femur to investigate the stress shielding effect of the femoral component on 
the periprosthetic bone.
The objective of this study was to investigate the effect of patellofemoral 
replacement on the expected stress-shielding of the distal femur leading to bone 
remodelling. For this purpose, the patellofemoral joint was modelled in a dynamic 
finite element knee model with and without a patellofemoral joint replacement. 
Furthermore, to investigate the effects of different patellofemoral replacement 
designs, we compared the stress shielding effect between the Journey PFJ 
patellofemoral prosthesis, the Richards II patellofemoral prosthesis, and the 
Genesis II total knee prosthesis.
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Methods
Knee joint geometry
A three-dimensional dynamic finite element knee model was designed consisting 
of a distal femur, patella, and patellar tendon. MR imaging data (slice thickness 
1.5mm, pixel dimension 0.43mm, field of view 220mm) from the right knee of a 
healthy 47 year old volunteer w ithout any known musculoskeletal disease were 
manually segmented using MIMICS 13 and 3-matic 4.2 software (Materialise, 
Belgium) to obtain a three-dimensional model of the osseous and cartilaginous 
geometries of distal femur and patella with patellar tendon and insertion of the 
quadriceps tendon (F igure 1).
Figure 1 Model geometries used in this study.
Physio log ica l model (A). Journey PFJ model (B). R ichards II PFA m odel (C). Genesis II TKA m odel (D).
Knee joint material properties
The trabecular bone of the distal femur was modelled as a homogenous isotropic 
linear elastic material (£=300 MPa, Poisson ratio v=0.30, density=1g/cm 3) (Linde 
1994, Heegaard et al. 2001, Beillas et al. 2004). The cortical bone was modelled 
as an orthotropic 2mm thick layer with material properties reported in Table 1 
(Heegaard et al. 2001, Taylor et al. 2002, Beillas et al. 2004). The patella was 
modelled as a homogenous isotropic linear elastic material (£=15000 MPa, 
Poisson ratio v=0.30, density=2g/cm 3), with a 2.5mm thick layer of homogenous 
isotropic linear elastic cartilage in contact with the femoral trochlea (Hart et al.
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1999, Beillas et al. 2004, Iranpour et al. 2008). Articular cartilage was assumed to 
behave as a single-phase linear elastic and Isotropic material (£=5 MPa, Poisson 
ratio v=0.46, denslty=1g/cm 3) (LI et al. 2001, Beillas et al. 2004, Pena et al. 2005, 
Pena et al. 2006). The friction coefficient between patella and trochlear groove 
was set at 0.001 based on experimental data (Besler et al. 2005). We assumed no 
differences In material properties between tendon and Insertion. The patellar 
tendon was modelled as an Isotropic and hyperelastic material (Pena et al. 2005), 
characterized by an Incompressible Neo-Hookean behaviour with the strain 
energy density (W) function: W = C1 (11 -  3), were C1 Is the Initial shear modulus 
(with value 2.75) (Pena et al. 2006) and 11 Is the first modified Invariant of the right 
Cauchy-Green strain tensor.
Table 1 Cortical bone material properties (Taylor et al. 2002).
E1 (MPa) E2 (MPa) E3 (MPa) G23 (MPa) G31 (MPa) G12 (MPa)
17900 18800 22800 7110 6580 5710
v12 v13 v23 v32 v21 v31
0.26 0.30 0.31 0.37 0.28 0.38
Knee joint load and constraints
The simulated motion consisted of a 10s loaded full squat (one cycle), starting 
from 0° until a maximum flexion angle of 120°. These settings match the experimental 
kinematics simulations performed In a previous in vitro analysis on physiological 
cadaver legs (Innocentl et al. 2009, Victor et al. 2009, Victor et al. 2010). The 
patella model was constrained by fixing the distal part of the patellar ligament and 
applying a quadriceps force distributed on the quadriceps Insertion on the 
proximal surface of the patella. Thus, the patella was allowed to move along the 
trochlear surface of the femur (Sharma et al. 2008). The magnitude and direction 
of the quadriceps force as well as the 3D kinematics of the femur were derived 
from the above mentioned tests on healthy, full leg cadaver specimens (Victor et 
al. 2010) and were applied using the Grood-Suntay coordinate system (Figure 2) 
(Grood and Suntay 1983), using as origin the midpoint between the condylar 
center (Innocentl et al. 2009, Victor et al. 2009, Victor et al. 2010).
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Since bone remodelling is thought to be provoked by the maximal stresses and 
strains experienced by the bone (Robling et al. 2006), rather than average daily 
stresses and strains, squatting rather than gait was preferred as the simulated 
motor task. Squatting is indeed a motor task which produces higher joint contact 
forces and therefore higher stresses and strains in the bone compared to gait 
(Zheng et al. 1998, Taylor et al. 2004). Moreover, as squatting gives rise to higher 
stresses, it should also induce a larger change in stress between the physiological 
and replaced knee. Finally, the analysis of a squat, up to 120°, was preferred 
since it reaches a larger range of motion compared to gait which is usually limited 
to 60° of flexion (ISO/CD 14243-1 1999).
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Physiological knee joint numerical model
The three-dimensional models of femur, patella and patellar tendon were imported 
in commercially available finite element analysis software (Abaqus 6.8EF-1, 
Dassault Systemes Simulia, Providence, Rl, USA). The models were meshed with 
2mm 6-noded triangle elements for the cortical and cartilage layers, and 2mm 
10-noded tetrahedral elements for the trabecular bone, patellar bone and patellar 
ligament. The number of elements for each component of the physiological knee 
model is given in Table 2. A convergence analysis was used to validate mesh 
adequacy.
Two regions of interest (ROI) were defined in the femoral bone: an anterior and a 
proximal ROI (Figure 3). The location of the ROIs was defined to fit the same 
regions as used in a previous BMD analysis following patellofemoral arthroplasty 
(van Jonbergen et al. 2010b). The ROIs were 1cm high in femoral proximo-distal 
direction and 1cm long in the anteroposterior direction. They spanned the entire 
medio-lateral width. During the dynamic simulation the average Von Mises stress 
in each ROI was calculated.
Table 2 Number of elements for each component for the different finite 
element models.
Finite element model Femur Patella Patellar Femoral Patellar
ligament component component
Physiological model 326737 93830 6914 / /
Journey PFJ model 496078 26791 6914 18396 13346
Richards II model 318408 9375 6914 19522 4636
Genesis II TKA model 160486 26791 6914 65503 13346
Journey PFJ numerical model
The geometries of the prosthetic components were taken from CAD files provided 
by the manufacturer (Smith&Nephew, Memphis, TN). The Journey PFJ femoral 
component (size medium) and 032  mm patellar component were incorporated in 
the knee model following the manufacturers’ instructions (Figure 1). The femoral 
component (oxidized zirconium or Oxinium™, Smith&Nephew, Memphis, TN, 
USA) was modelled as an isotropic linear elastic material (£=97905 MPa, Poisson
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Figure 3 Model of distal femur with anterior (A) and proximal (B) regions of 
Interest (ROI).
ratio v=0.3, denslty=6.62 g/cm 3) (Zirconium Products: Technical Data Sheet 
2003). The UHMWPE patellar component was modelled as a non-linear elasto- 
plastlc material (£=684.65 MPa, Polsson ratio v=0.45) (Godest et al. 2002, Halloran 
et al. 2005, Innocentl et al. 2009). A 2mm cement layer with linear elastic material 
properties (£=3000 MPa, Polsson ratio v=0.3) was modelled between the 
prosthetic components and the cut bone surfaces (Janssen et al. 2008, 
Vanlnbroukx et al. 2009). Contact between cement and bone was modelled using 
a node-to-surface contact algorithm. The frictional coefficient between the 
UHMWPE patellar component and the Oxlnlum femoral component was set at 
0.04 based on experimental data (Poggle et al. 1992). The models were meshed 
with 2mm 6-noded triangle elements for the cortical bone and cement layers, and 
2mm 10-noded tetrahedral elements for the cancellous bone, patellar bone, 
femoral component, patellar component and patellar ligament. The number of 
elements for each component of the Journey PFJ model Is given In Table 2. 
A convergence analysis was used to validate mesh adequacy.
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We defined an anterior and a posterior ROI in the same positions and with the 
same dimensions as in the physiological model. During the dynamic simulation 
the average Von Mises stress in each ROI was recorded.
Richards type II numerical model
A CAD file of a Richards II patellofemoral prosthesis (Smith&Nephew, Memphis, 
TN, USA) was obtained by a 3D scan of a real component (size Small). The 
geometries of the femoral and patellar components were incorporated in the 
model using the previously described surgical technique (van Jonbergen et al. 
2010d) (Figure 1). The femoral component (CoCr) was modelled as an isotropic 
linear elastic material (£=240000 MPa, Poisson ratio v=0.3) (Davis 2003). The 
material properties of both the patellar component (UHMWPE) and cement were 
the same as in the Journey PFJ model. Also, the contact and mesh properties 
were the same as in the Journey PFJ model. We used a friction coefficient of 0.08 
in the contact zone between the polyethylene patellar component and the CoCr 
femoral trochlear component (Poggie et al. 1992). The number of elements for 
each component of the Richards II model is reported in Table 2. A convergence 
analysis was used to validate mesh adequacy.
We defined an anterior and a posterior ROI in the same positions and with the 
same dimensions as in the physiological model. During the dynamic simulation 
the average Von Mises stress in each ROI was recorded.
Genesis II total knee prosthesis numerical model
The geometries of the prosthetic components were taken from CAD files provided 
by the manufacturer (Smith&Nephew, Memphis, TN, USA). The Genesis II 
posterior stabilized total knee femoral component (size 5) and 032m m  patellar 
component were incorporated in the knee model following the manufacturers’ 
instructions (Figure 1). The Genesis II total knee prosthesis was chosen for the 
total knee model because the geometry of the articular surface of the femoral 
component of this prosthesis is exactly the same as the geometry of the articular 
surface of the Journey PFJ femoral component. The material properties of the 
femoral component (Oxinium™), patellar component and cement were the same 
as in the Journey PFJ model. Also, the contact, friction and mesh properties were 
the same as in the Journey PFJ model. The number of elements for each 
component of the Genesis II model is given in Table 2. A convergence analysis 
was used to validate mesh adequacy.
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We defined an anterior and a posterior ROI in the same positions, and with the 
same dimensions as in the physiological model. During the dynamic simulation 
the average Von Mises stress in each ROI were recorded.
Results
Figures 4 and 5 show the average Von Mises stress in the anterior and proximal 
ROIs in the 4 models estimated by the dynamic finite element simulation as a 
function of time. Figures 6 and 7 show the average Von Mises stress in the 
anterior and proximal ROI in the 4 models estimated by the dynamic finite element 
simulation for 4 different flexion angles.
Overall, the average Von Mises stress in both ROIs increased with the flexion 
angle. Maximum values of 2 .8-3.8  MPa were reached at 90° flexion angle for the 
anterior ROI, and 1.4-1.6 MPa for the proximal ROI.
During deep knee flexion, the average Von Mises stresses in the anterior ROI with 
the Journey PFJ design were comparable to the physiological knee. The Richards 
II design demonstrated lower average Von Mises stress in the anterior ROI 
compared with the physiological knee, and the Genesis II total knee design 
demonstrated the lowest average Von Mises stress. The lower average Von Mises 
stress in the Richards II design was most pronounced at 90 degrees of flexion.
The average Von Mises stress in the proximal ROI was similar for both patellofemoral 
designs and the physiological model, with slightly lower average Von Mises stress 
for the Genesis II total knee prosthesis.
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Average Von Mises Stress Anterior ROI
Physiological Journey PFJ ■ ■ 'Richards II PFA 'Genesis IITKA
Time (s)
Figure 4 Average Von Mises stress in the anterior ROI in the 4 models as 
a function of time.
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Figure 6 Average Von Mises stress in the anterior ROI in the 4 models for 
4 different flexion angles.
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Figure 7 Average Von Mises stress in the proximal ROI in the 4 models for 
4 different flexion angles.
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Discussion
The aim of the current study was to evaluate the effect of patellofemoral joint 
replacement on the expected stress-shielding of the distal femur leading to bone 
remodelling. We modelled a patellofemoral joint in a finite element knee model 
with and without a patellofemoral joint replacement. In order to investigate the 
effects of different patellofemoral replacement designs, we also compared 
the stress shielding effect between the Journey PFJ patellofemoral prosthesis, 
the Richards II patellofemoral prosthesis, and the Genesis II total knee prosthesis.
In summary, our dynamic finite element modelling demonstrated comparable Von 
Mises stress in the anterior region of interest for the Journey PFJ design and the 
physiological knee. The Richards II design demonstrated lower average Von 
Mises stress in the anterior region of interest compared with the physiological 
knee, and the Genesis II total knee design demonstrated the lowest average Von 
Mises stress. The average Von Mises stress in the proximal region of interest was 
similar for both patellofemoral designs and the physiological model, with a slightly 
lower average Von Mises stress for the Genesis II total knee prosthesis.
Stress shielding behind the anterior flange of a patellofemoral prosthesis may 
result in mechanically induced bone remodelling with resulting decrease in BMD. 
Our Journey PFJ model predicted no significant stress shielding, implying that 
the physiological strains are maintained. However, the Richards II model predicted 
a reduction in average Von Mises stress compared to the physiological model. 
This is in agreement with the recently reported results of clinical dual-energy X-ray 
absorptiometry (DXA) measurements obtained in 14 patients (van Jonbergen et al. 
2010b). In this prospective 1-year DXA study a 15% decrease in BMD was found 
behind the anterior flange of the Richards type II patellofemoral prosthesis.
The observed differences in the stress shielding effect between the Richards II 
and Journey PFJ prosthesis may result from differences in both material and 
geometrical properties. The Richards II prosthesis is a first-generation CoCr 
prosthesis. The non-anatomic trochlear component is highly constrained with a 
deep central groove, and the polyethylene patellar component has a longitudinal 
ridge. In addition, the femoral component has an approximately 2cm long central 
fixation peg for added stability. In contrast, the Journey PFJ prosthesis is considered 
a third generation patellofemoral prostheses. The implant is characterized by a
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broad anatomical trochlear component made of oxidized zirconium (Oxinium™) 
which has a coefficient of friction that is half that of CoCr. There are 4 small fixation 
pegs on the posterior aspect of the femoral component. The stress shielding 
effect of the Richards II prosthesis was most pronounced at 90° of flexion. At this 
flexion angle, the patella contacts the femur below the position of the central 
fixation peg and thus the stress shielding effect of the peg is most pronounced in 
this configuration.
The curve of the average Von Mises stress in the anterior ROI for the Journey PFJ 
prosthesis features a gradual transition from the Richards II prosthesis curve 
(from extension to early flexion) to the physiological curve (between early flexion 
and deep flexion) (Figure 4). This transition can be explained most probably by 
the fact that the Journey PFJ femoral component is shorter in the sagital plane 
than the Richards II component. As a result, in deep flexion the patellar button 
contacts the native femoral surface beyond 90 degrees of flexion while in the 
Richards II design there is still contact between the femoral component and the 
patellar button. Moreover the Richards II patellar and femoral components are 
highly congruent, forcing the patellar component to remain within the femoral 
component medio-laterally within the entire flexion range.
After total knee replacement, the BMD of the distal femur decreases by 16-36% 
within one year because of the femoral com ponent’s stress-shielding effect (Liu 
et al. 1995, Petersen et al. 1995, Karbowski et al. 1999, Spittlehouse et al. 1999, 
van Loon et al. 2001, Soininvaara et al. 2004, Abu-Rajab et al. 2006). Finite 
element analyses have shown that with a bonded femoral component, the 
predicted long-term bone loss would occur at the most distal part of the femur 
and behind the anterior part of the prosthesis (Tissakht et al. 1996, van Lenthe et 
al. 1997). Only one previous study reported results from a finite element knee 
model in patellofemoral joint replacement (Morra and Greenwald 2006). Using 
the geometries of the Low Contact Stress (LCS), Vanguard, and Scout 
patellofemoral prostheses, a three-dimensional finite element model of each 
particular design was created. Stress distributions within the patellar components 
were calculated for three common daily activities: walking, ascending stairs, and 
rising from a chair. Only static loading was applied with 420N patellofemoral joint 
reaction force in 15° of flexion (walking gait), 1760N in 45° of flexion (stair ascent), 
and 1950N in 90° of flexion (chair rise). Based on these models, the authors 
concluded that different patellofemoral implant design geometries influence the
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polymer stress within the patellar component. To minimize contact and 
delamination stresses, they further stated that contemporary designs should 
employ a broad trochlear groove to maximize congruent patellar component 
contact. No attempt was however made to evaluate for altered stress distributions 
In the peri prosthetic distal femur. In an experimental setup using tri-axial strain 
gauges in synthetic femurs before and after Journey PFJ patellofemoral joint 
replacement, Meireles et al. determined the strain shielding effect in the distal 
femur (Meireles et al. 2010). Although a strain shielding effect was found, the 
results are difficult to interpret as only static loading of the patellofemoral joint 
was evaluated in 12, 50, and 90 degrees of flexion. The results showed a reduction 
in strain in the medial and distal regions of the femur when deep bending occurred, 
with higher values of strain in the anterior region proximal to the prosthesis. This 
distal diaphyseal increase in strain has also been noted in finite element models 
with total knee replacement (van Lenthe et al. 1997).
Strengths of the current study include the fact that it is the first to specifically 
evaluate for the stress-shielding effect of a patellofemoral prosthesis, and that we 
compared the stress-shielding effect of 3 different patellofemoral replacement 
designs. However, correct interpretation of results obtained from numerical 
models requires careful consideration of several important issues (Viceconti et al. 
2005). Finite element modeling is subject to limitations due to inherent uncertainties 
concerning geometry, load situation, and material properties. Although the results 
of our modelling are in agreement with the observed decrease of distal femoral 
bone mineral density after patellofemoral replacement, validation of our model 
requires more clinical data on the decrease of distal femoral bone mineral density 
with other patellofemoral prosthesis designs.
Conclusions
Dynamic finite element analyses of knee models with a patellofemoral joint 
replacement predict a decrease in strain energy density behind the anterior flange 
of the femoral component. This reduction was more pronounced in the Richards
II design than in the Journey PFJ design, and may be related to specific design 
properties.
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Survey on circum patellar e lectrocautery
Abstract
In tro d u c tio n : Anterior knee pain following total knee arthroplasty (TKA) is 
estimated to occur in 4 to 49% of patients. Some orthopedic surgeons use 
circumpatellar electrocautery (diathermy) to reduce the prevalence of postsurgical 
anterior knee pain; however, the extent of its use is unknown.
M ateria ls  and  M e thodo logy : In April 2009, a postal questionnaire was sent to all 
98 departments of orthopedic surgery in The Netherlands. The questions focused 
on the frequency of total knee arthroplasties, patellar resurfacing, and the use of 
circumpatellar electrocautery.
Results: The response rate was 92%. A total of 18,876 TKAs, 2,096 unicom part­
mental knee arthroplasties, and 215 patellofemoral arthroplasties are performed 
yearly in The Netherlands by the responding orthopedic surgeons. Of the 
orthopedic surgeons performing TKA, 13% always use patellar resurfacing in TKA 
for osteoarthritis, 49% use selective patellar resurfacing, and 38% never use it. 
Fifty-six percent of orthopedic surgeons use circumpatellar electrocautery when 
not resurfacing the patella, and 32% use electrocautery when resurfacing the 
patella.
C onclus ion : There is no consensus among Dutch orthopedic surgeons on the 
use of patellar resurfacing or circumpatellar electrocautery in total knee 
replacement performed for osteoarthritis. A prospective clinical trial is currently 
underway to fully evaluate the effect of circumpatellar electrocautery on the 
prevalence of anterior knee pain following TKA.
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Introduction
An estimated 4 to 49% of patients report anterior knee pain following total knee 
arthroplasty (TKA) (Wood et al. 2002, Waters and Bentley 2003, Popovic and 
Lemaire 2003, Burnett et al. 2004, Burnett et al. 2007, Smith et al. 2008). 
The cause is unknown, but is hypothesized to be related to patient characteristics 
(Barrack and Burak 2001, Wood et al. 2002, Smith et al. 2004), prosthetic design 
(Popovic and Lemaire 2003, Skwara et al. 2008, Breugem et al. 2008), operative 
technique (Fern et al. 1992), and/orthe use of patellar resurfacing (Cameron 1991, 
Wood et al. 2002, Waters and Bentley 2003). Both the peripatellar soft tissues and 
the infrapatellar fat pad have been implicated as the source of anterior knee pain 
(Maculé et al. 2005, Lehner et al. 2008). Immunohistochemical studies on 
innervation of the anterior knee demonstrated substance-P nociceptive afferent 
fibers in the peripatellar soft tissues (Wojtys et al. 1990). Production of a lesion in 
these pain receptors using electrocautery (diathermy) could theoretically achieve 
desensitization or denervation of the anterior knee (Moati and Zucman 1987, 
Maralcan et al. 2005, Vega et al. 2006).
Some orthopedic surgeons perform circumpatellar electrocautery to reduce the 
prevalence of anterior knee pain after TKA. The extent of its use in clinical practice 
both in The Netherlands and elsewhere is at present unknown. We aimed to 
determine the prevalence of circumpatellar electrocautery performed during TKA 
for osteoarthritis in The Netherlands.
Materials and methodology
In April 2009, a postal questionnaire with cover letter and postage free, addressed 
return envelope was sent to all 98 departments of orthopedic surgery in The 
Netherlands. The questions related to TKA for osteoarthritis (but not rheumatoid 
arthritis), patellar resurfacing, and the use of circumpatellar electrocautery. 
Furthermore, the questionnaire evaluated the number of orthopedic surgeons in 
each practice, the number performing knee replacement surgery, and the number 
and type of knee arthroplasties performed (TKA, unicompartmental arthroplasty, 
and patellofemoral arthroplasty).
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If after 3 weeks no completed questionnaire was received, a reminder with a copy 
of the questionnaire was sent. Remaining nonresponders were contacted by 
telephone after 6 weeks.
Results
The response rate was 62% after the first questionnaire, 82% after repeat mailing, 
and 92% after telephone contact.
A total of 18,876 TKAs, 2,096 unicompartmental knee arthroplasties, and 215 
patellofemoral arthroplasties are performed yearly In The Netherlands by 383 of 
the 477 responding orthopedic surgeons; 80% of responding surgeons perform 
knee arthroplasty. Among respondents, the average number of TKAs by surgeons 
who perform knee replacements was 50 per year (range, 18 to 101).
Of the orthopedic surgeons performing TKA, 13% always use patellar resurfacing 
In TKA for osteoarthritis, 49% use selective patellar resurfacing, and 38% never 
use It.
Fifty-six percent of orthopedic surgeons performing knee replacements use 
circumpatellar electrocautery when not resurfacing the patella, and 32% use 
electrocautery when resurfacing the patella.
Surgeons were questioned regarding the clinical conditions that were treated with 
selective resurfacing. A total of 78% of orthopedic surgeons who use selective 
resurfacing mentioned articular cartilage or severity of patellofemoral osteoarthritis, 
34% preoperative anterior knee pain, 20% patellofemoral instability, 11% poor 
congruency of the native patella with the prosthetic trochlear groove, 1% the type 
of knee prosthesis used, and 4% reported other indications.
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Discussion
The source of anterior knee pain after TKA is poorly understood; both the 
peripatellar soft tissues and the infrapatellar fat pad have been implicated (Maculé 
et al. 2005, Lehner et al. 2008). Immunohistochemical studies on innervation of 
the anterior knee demonstrate hyperinnervation of the peripatellar soft tissues 
(Wojtys et al. 1990). Production of a surgical lesion in these pain receptors could 
theoretically achieve desensitization or denervation of the anterior knee (Moati 
and Zucman 1987, Maralcan et al. 2005, Vega et al. 2006). The use of circumpatellar 
electrocautery in order to reduce the prevalence of anterior knee pain after TKA is 
reported by several authors (Keblish et al. 1994, Barrack and Burak 2001, 
Pellengahr et al. 2002, Kim et al. 2008, van Hemert et al. 2009, Seo et al. 2009). 
However, only one clinical study has addressed the efficacy of circumpatellar 
electrocautery in TKA to date (Saoud 2004). Results showed improved pain relief 
after patellar denervation, but the inferior study design of this trial prevents 
confident application of this procedure to clinical practice. Prior to the current 
study, the extent to which surgeons use circumpatellar electrocautery in clinical 
practice was unknown.
The use of patellar resurfacing varies between countries. According to the 2009 
Annual Report of the Swedish Knee Arthroplasty Register (The Swedish Knee 
Arthroplasty Register 2009), patellar resurfacing is used in less than 10% of TKA 
cases in Sweden, 70% of cases in Denmark, 5% in Norway, and 45% of cases in 
Australia. The reasons forthese regional differences are unclear. In 1996, a survey 
of TKA techniques in the United Kingdom showed 32% of orthopedic surgeons 
always performing patellar resurfacing, 49% sometimes using resurfacing, and 
19% never using it (Phillips et al. 1996). This great disparity as to whether the 
patella should be resurfaced was apparent in the present study as well, with 
surgeons reporting always, selectively, or never performing resurfacing in 13, 49 
and 38 percent, respectively. Clearly, the ongoing debate on the need for patellar 
resurfacing has not resolved this important issue.
Strengths of the current study include the high response rate and the fact that our 
study is the first to determine the prevalence of circumpatellar electrocautery 
among orthopedic surgeons. The present survey has some limitations that should 
be considered. Firstly, we cannot rule out the possibility that a nonresponse bias 
was introduced using the survey. To reduce the chance of a nonresponse bias,
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we maximized the response rate by designing a mixed-mode (mail and telephone) 
survey following the recommendations by others (Sprague et al. 2009). No non­
response analysis was performed to determine if characteristics of respondents 
and non-respondents differ. Additionally, we assumed the group of responders to 
be a representative sample of all Dutch orthopedic surgeons. Secondly, we did 
not inquire about the technique used to perform circumpatellar electrocautery. 
Currently, there is no adequate description of the technique in the literature. One 
could argue that the different procedures collectively described as patelloplasty 
may also result in partial denervation. These patelloplasties consist of various 
combinations of debriding or shaving of the patella, removal of osteophytes, 
peripatellar synovectomy, and reduction of size of the patella (Wood et al. 2002, 
Popovic and Lemaire 2003, Burnett et al. 2004, Oh et al. 2006, Burnett et al. 2007, 
Smith et al. 2008). As patellar resurfacing requires removal of osteophytes and 
synovial tissue to enable accurate resection and restore patellar thickness, this 
may, at least in part, also be considered denervation. Thirdly, the survey was 
limited to orthopedic surgeons in The Netherlands, and the results may therefore 
not be representative for the practice pattern in other countries.
A prospective, randomized controlled trial comparing TKA with and without the 
use of circumpatellar electrocautery is currently underway to determine the effect 
of this intervention on post-TKA anterior knee pain (Netherlands Trial Register, 
NTR1326).
Conclusion
Of the Dutch orthopedic surgeons performing TKA, 56% use circumpatellar 
electrocautery when not resurfacing the patella, and 32% use diathermy when 
resurfacing the patella. A prospective clinical trial is currently underway to fully 
evaluate the effect of circumpatellar electrocautery on the prevalence of anterior 
knee pain following TKA.
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Circumpatellar electrocautery in total knee arthroplasty
Abstract
B ackground : Patellofemoral com plications may compromise the outcome of 
total knee arthroplasty. The efficacy of circumpatellar electrocautery in reducing 
the risk of postsurgical anterior knee pain is unknown.
M ethods: We conducted a single-centre, outcom e-assessor and patient-blinded, 
parallel group, randomized controlled trial to determine the clinical efficacy of 
circumpatellar electrocautery versus no electrocautery in total knee arthroplasty 
w ithout patellar resurfacing. Patients requiring knee replacement for primary knee 
osteoarthritis were randomly assigned to circumpatellar electrocautery or to no 
electrocautery. The primary outcome measure was the prevalence of anterior 
knee pain. Secondary outcomes included standardized clinical and patient- 
reported outcomes (KSKS, KSFS, and WOMAC scores).
Results: A total of 131 knees received circumpatellar electrocautery, and 131 
knees received no electrocautery. The overall prevalence of anterior knee pain at 
1-year follow-up was 26% (20% to 31%), with 19% (12% to 26%) in the intervention 
group, and 32% (24% to 40%) in the control group (p = 0.02). Relative risk reduction 
(RRR) was 40% (9% to 61%) and number needed to treat (NNT) 7.7 (4.3 to 41.4). 
The intervention group demonstrated better total WOMAC scores at 1-year 
follow-up compared with the control group (p = 0.04). Postoperative KSKS 
(p=0.14), KSFS (p = 0.49), and adverse events were similar in both groups. 
C onclus ions: In patients with primary knee osteoarthritis having total knee 
arthroplasty w ithout patellar resurfacing, the use of circumpatellar electrocautery 
results in a lower prevalence of anterior knee pain and better WOMAC scores at 
the 1-year follow-up compared with no circumpatellar electrocautery, but not in 
better standardized clinical outcomes (Netherlands Trial Register NTR1326).
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Introduction
Patellofemoral complications may compromise the outcome of total knee 
arthroplasty and are the primary non-infectious indication for revision surgery 
(Eisenhuth et al. 2006). Anterior knee pain is reported to occur in 4-49%  of 
patients following primary total knee arthroplasty (Wood et al. 2002, Popovic and 
Lemaire 2003, Waters and Bentley 2003, Smith et al. 2004, Burnett et al. 2004, 
Arbuthnot et al. 2004, Oh et al. 2006, Campbell et al. 2006, Oztuna et al. 2007, 
Burnett et al. 2007, Breugem et al. 2008, Kim et al. 2008, Smith et al. 2008, Erak 
et al. 2009, Burnett et al. 2009). The cause is unknown, but may be related to 
patient characteristics (Wood et al. 2002, Smith et al. 2004), degree of patellar 
cartilage wear (Rodriguez-Merchan and Gomez-Cardero 2010), prosthetic design 
(Popovic and Lemaire 2003, Skwara et al. 2008, Breugem et al. 2008), operative 
technique (Fern et al. 1992, Barrack et al. 2001b, Maculé et al. 2005), and the use 
of patellar resurfacing (Wood et al. 2002, Waters and Bentley 2003, Calvisi et al. 
2009). Both the peripatellar soft tissues and the infrapatellar fat pad have been 
implicated as a source of anterior knee pain (Maculé et al. 2005, Lehner et al.
2008). Immunohistochemical studies on innervation of the anterior knee 
demonstrated substance-P nociceptive afferent fibers in the peripatellar soft 
tissues (Wojtys et al. 1990). Therefore, production of a lesion in these pain 
receptors using electrocautery could theoretically achieve desensitization or 
denervation of the anterior knee with less postsurgical anterior knee pain (Moati 
and Zucman 1987, Maralcan et al. 2005, Vega et al. 2006, McPherson 2006).
Several research papers have described the use of circumpatellar electrocautery 
in total knee arthroplasty with (Barrack and Burak 2001, Larson et al. 2001, van 
Hemert et al. 2009) and without patellar resurfacing (Pellengahr et al. 2002, Kim 
et al. 2008, van Hemert et al. 2009). To date, only one clinical study specifically 
addressed the results of circumpatellar electrocautery in primary total knee 
arthroplasty (Saoud 2004). Results showed improved pain relief after patellar 
denervation, but the inferior study design prevents confident application of this 
procedure to clinical practice. A recent postal survey with a 92% response rate 
revealed that 56% of orthopedic surgeons in The Netherlands use circumpatellar 
electrocautery when not resurfacing the patella, and 32% use electrocautery 
when resurfacing the patella (van Jonbergen et al. 2010a).
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We hypothesized that primary total knee arthroplasty with circumpatellar 
electrocautery leads to partial denervation of the anterior knee with resulting 
better pain relief and patient reported clinical outcomes than primary total knee 
arthroplasty without circumpatellar electrocautery. The primary objective of the 
present blinded, prospective, parallel randomized study was therefore to 
determine the clinical effect of circumpatellar electrocautery in total knee 
arthroplasty w ithout patellar resurfacing with regard to the prevalence of anterior 
knee pain. Secondary objectives were to evaluate for differences in standardized 
clinical and patient-reported outcomes.
Materials and methods
Study design
In 2008, a prospective, outcome-assessor and patient-blinded, parallel group, 
randomized clinical trial adhering to the CONSORT statement 2001 was initiated 
(Moher et al. 2001, Boutron et al. 2008a). The study was approved by the Regional 
Ethics Committee (NL21569.075.08, February 2008) and Institutional Review 
Board. Before start of the study, the protocol was registered with the Netherlands 
Trial Register (NTR1326).
Study population
All patients who were to have total knee arthroplasty for primary knee osteoarthritis 
were evaluated for inclusion in the study. They were not admitted to the study if 
any of the following criteria were present: isolated patellofemoral osteoarthritis, 
contralateral patellar resurfacing (primary or as revision), insufficient Dutch 
language skills, total hip replacement or contralateral total knee replacement 
within the study period or less than oneyear before entering the study, inflammatory 
arthritis, a history of patellar fracture, prior patellectomy, patellofemoral instability, 
prior unicondylar knee replacement, previous high tibial or distal femoral 
osteotomy, any prior operation involving the extensor mechanism, a severe 
medical disability that limits the ability to walk, and disabling disease involving 
other joints of the lower extremities.
With allowance for patients whose data could not be evaluated, 352 consecutive 
patients were recruited by all 5 orthopedic surgeons performing total knee 
arthroplasty, and 300 provided written informed consent (Figure 1).
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Figure 1 CONSORT flow diagram. Enrollment of patients, treatment 
allocation and completion of the study.
*  Denotes su rgeon ’s preference for e lectrocautery.
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Baseline studies
All eligible patients were preoperatlvely assessed by one of the five participating 
orthopedic surgeons who obtained the Knee Society Knee Score (KSKS) and 
Knee Society Functional Score (KSFS). The Dutch version of the 24-Item Western 
Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Llkert version 
3.0 was completed by all patients.
Study treatment
All 300 patients participated In a standardized preoperative workup program 
which has been In use at our Institution since 2004. This program consists of 
patient education, physical therapy Instructions for walking with crutches, and 
preoperative screening by an anesthesiologist. Patients were admitted to the 
hospital on the morning of surgery.
Total knee arthroplasty was performed by all five participating general orthopedic 
surgeons In a standardized manner according to the manufacturers’ Instruction. 
Patients were operated under spinal anesthesia combined with a femoral nerve 
block and with pneumatic tourniquet control. Blinding of the patient was achieved 
by shielding the subject’s view by a vertical drape. In all cases the NexGen LPS 
(NexGen, Zimmer, Warsaw, IN) posterior stabilized, non-rotating, total knee 
prosthesis was used without patellar resurfacing. After a midline skin incision and 
medial arthrotomy, the patella was everted to the lateral side, and remained in this 
position until stability was assessed using the trial femoral and tibial components. 
In all cases, the patellar fat pad was resected to adequately visualize the proximal 
tibia. We employed five degrees of distal femoral valgus, and three degrees of 
external rotation relative to the posterior condyles. After cementing both femoral 
and tibial components, the degree of damage to the patellar articular cartilage 
was assessed according to the Outerbridge grading system, and the patella was 
debrided by removal of osteophytes only if considered necessary for patellar 
tracking. Also, a lateral release at least 2cm lateral to the lateral border of the 
patella was only performed as clinically indicated after a ‘no thum bs’ assessment 
of patellofemoral instability on passive testing of the range of motion.
Randomization
Patients were randomly assigned to receive total knee arthroplasty with circum ­
patellar electrocautery (intervention group) or to receive total knee arthroplasty 
w ithout circumpatellar electrocautery (control group). The randomization was
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performed during surgery using sequentially numbered, opaque sealed envelopes, 
each bearing on the outside only a number. All 300 envelopes containing a total 
of 150 instructions for circumpatellar electrocautery, and 150 instructions for no 
additional treatment were prepared before start of the study by an assistant who 
did not participate in the study, using computer generated random-number tables.
To maintain allocation concealment, the next available numbered envelope was 
opened by a nurse in the operating room after cementing both femoral and tibial 
components, assessment of patellar cartilage, and proper management of patello- 
femoral instability. The contained instructions described the required further 
treatment of the patella: subsequent circumpatellar electrocautery, or no circum ­
patellar electrocautery. The treatment assignment was not revealed to the patient. 
In case electrocautery was required as per instruction, diathermy was performed 
using the Valleylab electrocautery unit (Valleylab Inc., Boulder, CO) with monopolar 
diathermy with powersetting 50W and use of coagulation. The technique employed 
only superficial electrocautery to a depth of no more than 1 mm in a circular (360 
degrees) fashion within 5 mm of the edge of the patella (Figure 2). After lavage, 
the medial arthrotomy, subcutaneous tissue, and skin were closed in layers over 
a suction drain. In case no electrocautery was required as per instruction, the 
knee was lavaged and closed in layers over a suction drain.
Postoperative management
All 300 patients received the same postoperative treatment according to an 
integrated pathway protocol with analgesia monitored by an anesthesiologist. 
Physical therapy followed an identical program in both groups with immediate 
postoperative protected weight bearing with crutches. Patients were discharged 
from hospital after four days if they were able to actively flex the operated knee to 
90 degrees. All patients routinely received antithrombotic prophylaxis with a low- 
molecular-weight heparin (Dalteparin) for six weeks. After six weeks full unrestricted 
weight bearing was allowed without walking aids. All patients had a scheduled 
clinical follow-up at 2 weeks, 8 weeks, and one year post-surgery. During 
follow-up, the radiological examination consisted of two radiographs (antero­
posterior standing and lateral non-weight bearing) at eight weeks and one year 
post surgery. All health care professionals following the participants after the 
surgical procedure were blinded to group assignment.
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Figure 2 Intra-operative photograph depicting circumpatellar electrocautery 
performed after cementing femoral and tibial components.
Surgeons’ expertise
The five participating general orthopedic surgeons perform a total of 300 total 
knee replacements yearly averaging more than fifty arthroplasties each, and each 
had five or more years of experience with the procedure and the type of knee 
prosthesis used. Figure 1 shows the number of patients treated by each surgeon 
in our study. We also assessed surgeon’s preference for either electrocautery or 
standard care (Figure 1).
Outcome measures
A trained nurse practitioner, who was blinded to the treatment arm, assessed the 
clinical outcome one year after total knee arthroplasty.
The primary outcome was the prevalence of anterior knee pain at one year after 
the intervention. To determine the prevalence of anterior knee pain, the Clinical 
Anterior Knee Pain Rating system as described by Waters and Bentley was used 
(Table 1) (Waters and Bentley 2003). Together with the question: ‘do you experience 
pain at the anterior side of the knee’, patients who responded affirmative were
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further questioned whether it interfered with activity, and whether its severity 
warranted further surgery.
The secondary outcomes at one year were assessed with the KSKS and KSFS 
scores obtained by the nurse practitioner, and with the WOMAC questionnaire 
completed by all patients.
Table 1 Clinical Anterior Knee Pain Rating system described by Waters and 
Bentley (Waters and Bentley 2003).
Rating Description
0 No pain
I Mild pain that does not intrude on daily activities
II Moderate pain that is a nuisance; patient not considering further
surgery
III Severe pain; patient considering further surgery
Statistical analysis
Baseline characteristics were analyzed by descriptive statistics using the mean and 
standard deviation for continuous variables and frequencies for categorical variables.
For the primary outcome measure, the Clinical Anterior Knee Pain Rating system 
was dichotomized. A Rating of I, II or III was coded as “presence of anterior knee 
pain”, while a rating of 0 was coded as “absence of anterior knee pain” (Waters 
and Bentley 2003). The prevalence of anterior knee pain in both groups including 
95%-confidence intervals were calculated, and the chi-squared test was used to 
compare the categorical data between the two study groups. A two-sided p-value 
of 0.05 was considered to indicate statistical significance. The relative risk 
reduction (RRR) and number needed to treat (NNT) with 95% confidence intervals 
were calculated.
For the three secondary outcome measures (KSKS, KSFS, and WOMAC), data 
were first assessed for normality using the Kolmogorov-Smirnov test with p<0.05, 
after which repeated measures ANOVA was used to analyze for differences over 
time between both groups. All analyses were performed according to the intention- 
to-treat principle.
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Before start of the study, sample size calculation was performed using estimates 
of the prevalence of anterior knee pain of 25% after total knee arthroplasty without 
patellar resurfacing (Waters and Bentley 2003). We considered a difference of 15 
percentage-polnts clinically relevant although no pilot study was performed, and 
no previous study assessed the prevalence of anterior knee pain after total knee 
arthroplasty with and w ithout the use of circumpatellar electrocautery. With use of 
a 15% effect size, significance level (alpha) of 0.05 using a two-sided test, and 
power of 80%, a sample size of 113 knees In each group would be required to 
detect a significant difference.
Results
Baseline characteristics of study population
Baseline demographic and clinical characteristics of both groups are summarized 
In Table 2. No statistically significant differences between groups were found with 
respect to these baseline characteristics. Figure 1 shows the disposition of the 
study participants outlined In a Consolidated Standards of Reporting Trials 
(CONSORT) diagram (Boutron et al. 2008a, Boutron et al. 2008b). Patients were 
Included between May 2008 and May 2009 with surgery performed between May 
2008 and June 2009. The 19 patients who were excluded after receiving the study 
Intervention did not differ with respect to baseline characteristics from the 19 
patients who were excluded after receiving the control treatment.
Surgical procedure
All patients received the allocated treatment. The number of knees requiring a 
lateral release was 8 In the Intervention group, and 9 In the control group.
Adverse events
Three knees, two knees In the Intervention group, and one knee In the control 
group, showed signs of a deep Infection within 6 weeks after arthroplasty and 
received adequate operative and antibiotic treatment. At the 1-year follow-up, 
these knees had no clinical signs of Infection of the total knee prosthesis. In three 
knees In the Intervention group and In one knee In the control group, manipulation 
under anesthesia was performed to Improve flexion after the fourth postoperative 
week. These patients obtained more than 90° of flexion at final review.
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Table 2 Baseline demographic and clinical characteristics of each group.
Characteristic Intervention Control p-value
group (n=131) group (n= 131)
Side (right : left) 77 : 54 81 : 50 0.71
Age at operation (years) 71 (8.0) 72 (7.9) 0.87
Sex (female : male) 95 : 36 84 : 47 0.14
Height (cm) 167 (9.1) 169 (9.2) 0.21
Weight (kg) 84 (14.7) 84 (15.4) 0.88
Body mass index (kg/m2) 30.1 (4.7) 29.4 (4.3) 0.22
ASA PS Classification 
ASA PS 1 13 10
0.46
ASA PS 2 105 102
ASA PS 3 13 19
Predominant location of 
pre-operative knee pain
Anterior 16 14
0.97
Medial 67 69
Posterior 3 2
Lateral 10 12
Generalized 35 34
Intra-operative cartilage patella 
(Outerbridge grading)
Grade 0 10 13
0.96
Grade 1 11 12
Grade 2 40 36
Grade 3 39 39
Grade 4 31 31
Mean duration of follow-up (years) 1.1 (0.1) 1.0 (0.1) 0.45
ASA PS, Am erican S ocie ty o f A nesthesio log is ts  Physical Status.
* C ontinuous va lues are given as the mean w ith  s tandard devia tion In parentheses.
No radiologic signs of patellar osteonecrosis were seen at 1-year follow-up (MelIoni 
et al. 2008).
Primary outcome measure
The overall prevalence of anterior knee pain at 1-year follow-up was 26% (95% 
confidence interval 20% to 31%). A statistically significant lower prevalence of
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anterior knee pain was found in the intervention group (19%; 95% confidence 
interval 12% to 26%) as compared to the control group (32%; 95% confidence 
interval 24% to 40%) (chi-squared test, p = 0.02). The number of knees in each 
group with grading according to the Clinical Anterior Knee Pain Rating system is 
presented in Table 3. The difference in proportions was statistically significant 
(chi-squared test, p=0.03). Use of circumpatellar electrocautery results in a 40% 
(95% confidence interval 9% to 61%) Relative risk reduction (RRR) for postsurgical 
anterior knee pain, with number needed to treat (NNT) 7.7 (95% confidence 
interval 4.3 to 41.4).
Table 3 Patient categories and prevalence of anterior knee pain at 1 year 
follow-up.
Intervention group Control group
Anterior Knee Pain Rating
(n=131) (n=131)
Grade 0 106 89
Grade I 18 24
Grade II 6 9
Grade III 1 9
Secondary outcome measures
The intervention group demonstrated better total WOMAC scores at 1-year 
follow-up compared with the control group (p = 0.04). Additional analysis of the 
component items within the WOMAC questionnaire demonstrated a statistically 
significant better WOMAC function subscale (p = 0.02) for the intervention group. 
However, no statistically significant differences for the WOMAC pain (p = 0.14) and 
stiffness subscales (p = 0.18) were noted between groups. No statistically 
significant differences were observed between the treatment groups for the 
change from baseline KSKS (p = 0.14) and KSFS scores (p=0.49) (Table 4). Also, 
for those patients reporting anterior knee pain, no statistically significant 
differences were found between the treatment groups for VAS scores for pain 
(p=0.65).
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Table 4 Clinical outcome after total knee arthrop lasty w ith preoperative and 
postoperative clinical scores.
Intervention Control group p-value
group (n=131) (n=131)
Knee Society Knee Score
Preoperative 51.7 (11.9) 52.7 (12.2)
Postoperative 92.4 (10.8) 90.4 (13.0) 0.14
Knee Society Function Score
Preoperative 54.4 (15.7) 54.4 (15.7)
Postoperative 86.5 (15.0) 84.4 (16.2) 0.49
WOMAC total score
Preoperative 56.6 (16.5) 57.0 (14.9)
Postoperative 16.3 (15.4) 21.6 (18.5) 0.04
WOMAC pain score
Preoperative 54.2 (17.9) 55.3 (17.7)
Postoperative 10.7 (15.1) 15.8 (17.8) 0.14
WOMAC stiffness score
Preoperative 58.8 (20.7) 59.1 (21.1)
Postoperative 23.2 (19.3) 28.2 (22.5) 0.18
WOMAC function score
Preoperative 57.0 (18.7) 56.3 (17.0)
Postoperative 15.3 (17.1) 20.4 (20.2) 0.02
W OMAC scores are norm alized and expressed on 0 -100  scales.
Discussion
In patients w ith primary knee osteoarthritis having total knee arthrop lasty w ithout 
patellar resurfacing, the use of clrcumpatellar electrocautery results In a lower 
prevalence of anterior knee pain at 1-year follow-up compared with no 
clrcumpatellar electrocautery, with a relative risk reduction of 40% for postsurglcal 
anterior knee pain. Moreover, we found better W OMAC scores In the Intervention 
group, mostly because of better scores In the function component of the WOMAC, 
suggesting that anterior knee pain may be associated w ith the functional results.
Both the presence and severity of anterior knee pain, together w ith standardized 
clinical and patient-reported outcomes were used to assess patient functioning at 
different levels (Poolman et al. 2009). We believe measuring outcomes at several
109
Circumpatellar electrocautery in total knee arthroplasty
levels In a conceptual framework of outcome measurement does not need 
correction for multiple endpoints since each endpoint measures different aspects 
of the patient’s wellbeing (Poolman et al. 2009). Correcting for multiple endpoints 
utilizing Bonferronl’s method, adjusting the significance level to p = 0.017 (0.05/3) 
would yield less striking results for our secondary endpoints.
To our knowledge, the present study Is the first to use a prospective randomized, 
assessor and patient blinded trial to Investigate the effect of circumpatellar 
electrocautery on the prevalence of anterior knee pain In patients undergoing 
total knee arthroplasty w ithout patellar resurfacing. Numerous studies have 
assessed the various factors thought to be related to anterior knee pain, Including 
patient characteristics (Wood et al. 2002, Smith et al. 2004), degree of patellar 
cartilage wear (Rodrlguez-Merchan and Gomez-Cardero 2010), prosthetic design 
(Popovlc and Lemalre 2003, Skwara et al. 2008, Breugem et al. 2008), operative 
technique (Fern et al. 1992, Barrack et al. 2001b, Maculé et al. 2005), and the use 
of patellar resurfacing (Wood et al. 2002, Waters and Bentley 2003, Calvlsl et al.
2009). Although some of these factors could be related to denervation, others are 
probably not. It Is thus probable that the occurrence of anterior knee pain after 
total knee arthroplasty Is multifactorial. Some of these variables may have 
Influenced our results. In a randomized controlled trial comparing patellar 
resurfacing with retention, weight but not body mass Index was associated with 
the development of anterior knee pain In the patients without patellar resurfacing 
(Wood et al. 2002). In our study, baseline characteristics Including weight, length 
and body mass Index did not differ between groups. We have however not 
stratified our analysis for weight or body mass Index. The degree of patellar 
cartilage wear Is another factor potentially Influencing the prevalence of anterior 
knee pain (Rodrlguez-Merchan and Gomez-Cardero 2010). Selective resurfacing 
has been recommended In Outerbrldge grade IV patellae as patients with 
Outerbrldge Class IV patellofemoral findings were 21 times more likely to require 
revision for patellar resurfacing than patients In whom Outerbrldge Class I, II, and
III findings were documented (Rodrlguez-Merchan and Gomez-Cardero 2010). 
We did not find a correlation between the prevalence of anterior knee pain and the 
extent of cartilage damage, and this lack of correlation has been reported by 
others as well (Barrack et al. 2001a, Wood et al. 2002, Burnett et al. 2004, Oh et 
al. 2006). We used the posterior stabilized, fixed-bearing NexGen prosthesis In all 
patients, use of which may result In a higher prevalence of anterior knee pain than 
observed with a mobile-bearing prosthesis (Breugem et al. 2008). We also employed
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total knee arthroplasty w ithout patellar resurfacing, as definite evidence for use of 
primary patellar resurfacing Is currently lacking (Calvlsl et al. 2009).
To enhance the generallzablllty of our research findings, we used broad Inclusion 
criteria and maximized the sample size. The study was undertaken at a single 
general teaching hospital by five general orthopedic surgeons using a commonly 
used prosthesis. Validity was maximized by parallel randomization and allocation 
concealment, adequate blinding of patient and outcome assessor, careful 
follow-up with no patients lost to follow-up, well defined Intervention and control 
procedures, and use of both standardized clinical and patient-reported outcomes. 
Most Importantly, we used outcome measures Important to patients rather than 
surrogate endpoints (Poolman 2009).
The mechanism by which clrcumpatellar electrocautery results In a lower 
prevalence of anterior knee pain could be that production of a lesion In the pain 
receptors resulted In desensltlzatlon or denervation of the anterior knee (Vega et 
al. 2006, McPherson 2006). By this mechanism, the different procedures collectively 
described as patelloplasty may also result In partial denervation. As patellar 
resurfacing requires removal of osteophytes and synovial tissue to enable 
accurate resection and restore patellar thickness, this may, at least In part, also 
result In denervation. After our study was completed, Gupta et al. reported a lack 
of Improvement after patellar rim electrocautery In total knee arthroplasty without 
patellar resurfacing (Gupta et al. 2010b). The procedures used In this retrospective, 
comparative cohort study leave much to be desired because matching was only 
done for age and sex while Introducing substantial bias by comparing results 
from two different surgeons; one performing electrocautery and the other not.
The number of procedure-related adverse events In our study compares favorably 
with data from the literature (Blom et al. 2004, Yercan et al. 2006). In theory, 
electrocautery could result In disruption of the patellar vascularization leading to 
osteonecrosis. No radiological signs of patellar osteonecrosis were noted at 
1-year follow-up. We followed our patients for 1 year. Some authors (Wood et al.
2002, Arbuthnot et al. 2004) reported a gradual decrease In anterior knee pain 
after total knee replacement, whereas others (Campbell et al. 2006) describe an 
Increase In the Incidence over time. To assess the long-term outcomes, we will 
re-evaluate the patients In the future because the clinical effect of clrcumpatellar 
electrocautery may diminish over time.
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Circumpatellar electrocautery in total knee arthroplasty
In summary, the results of this randomized controlled trial provides evidence that 
the use of circumpatellar electrocautery In total knee arthroplasty w ithout patellar 
resurfacing results In a lower prevalence of anterior knee pain and better WOMAC 
scores at 1-year follow-up compared with no circumpatellar electrocautery. 
Considering the significant clinical benefit of this simple procedure and the lack 
of harms we suggest routine use of circumpatellar electrocautery In total knee 
arthroplasty w ithout patellar resurfacing.
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Chapter 9
Background
Isolated patellofemoral joint osteoarthritis Is a degenerative disorder of the knee 
estimated to occur In approximately 4% to 24% of patients with osteoarthritis of 
the knee (Barrett, Jr. et al. 1990, McAllndon et al. 1992, Davies et al. 2002). Mild 
Isolated patellofemoral osteoarthritis Is significantly associated with pain, stiffness, 
and functional limitations (Hunter et al. 2003, Duncan et al. 2009). Most patients 
can be successfully treated with nonoperative measures. In patients with disabling 
complaints who are unresponsive to non-surglcal treatment, a multitude of 
operative treatment modalities have been used, and patellofemoral joint 
replacement can be considered for selected patients (Grelsamer and Stein 2006, 
Leadbetter et al. 2006).
In patellofemoral joint replacement, the femorotlblal compartments, with cruciate 
ligaments and menisci, are spared, which may preserve the physiological 
kinematics of the femorotlblal joint. The reported clinical results are related to 
patient selection, prosthetic design properties, and surgical technique (Leadbetter 
et al. 2005, Leadbetter et al. 2006, Gupta et al. 2010a). Development of painful 
femorotlblal osteoarthritis Is an Important reason for converting a patellofemoral 
joint replacementto atotal knee replacement, and predictive factors for developing 
femorotlblal osteoarthritis remain unidentified. The results of conversion may be 
compromised by prior patellofemoral joint replacement.
Patellofemoral complications are the primary non-lnfectlous Indication for revision 
surgery after primary total knee replacement (Elsenhuth et al. 2006). Some orthopaedic 
surgeons use electrocautery of the patellar rim to reduce the prevalence of anterior 
knee pain after total knee arthroplasty.
Aims of the thesis
The alms of this thesis were formulated as follows:
■ To clarify the role of nonoperative and operative treatment modalities In Isolated 
patellofemoral osteoarthritis;
■ To evaluate the long-term outcomes of a patellofemoral prosthesis, and to 
Identify the different failure mechanisms;
■ To Investigate whether prior patellofemoral joint replacement has an effect on
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the clinical outcome of later conversion to total knee replacement forfemorotibial 
osteoarthritis;
■ To evaluate the possible loss of distal femoral bone after patellofemoral joint 
replacement;
■ To investigate the efficacy of circumpatellar electrocautery in total knee 
replacement.
Key findings of the thesis
In Chapter 2, we present a systematic review of the literature on the nonoperative 
and operative treatment options for isolated patellofemoral osteoarthritis. Our results 
show that presently there are no publications describing the long-term outcomes 
(more than 1 year) of nonoperative treatment. A multitude of studies with a generally 
low methodological quality reported the short- and long-term results of surgical 
management. Despite these limitations, we present treatment recommendations 
based on the best available evidence. Using the GRADE approach (Grading of 
Recommendations Assessment, Development and Evaluation) for each intervention, 
both a recommendation for the use in clinical practice and the quality of the 
evidence supporting that recommendation was assessed. Nonoperative treatment 
using physical therapy (GRADE: high quality, weak recommendation for use), 
taping (GRADE: moderate quality, weak recommendation for use), or injection 
therapy (GRADE: very low quality, weak recommendation for use) may result in 
short-term relief. Joint-preserving surgical treatment may result in insufficient, 
unpredictable, or only short-term improvement (GRADE: low quality, weak 
recommendation against use). Total knee replacement with patellar resurfacing 
results in predictable and durable good results (GRADE: low quality, weak 
recommendation for use). Outcome after patellofemoral joint replacement in 
selected patients is good to excellent (GRADE: low quality, weak recommendation 
for use).
Chapter 3 describes the long-term outcomes of the Richards II patellofemoral 
prosthesis. After a median of 13.3 years follow-up in 181 patellofemoral 
arthroplasties, we found no differences in implant survival between patients with 
primary isolated patellofemoral osteoarthritis, posttraumatic patellofemoral 
osteoarthritis, and patellofemoral osteoarthritis with a previous realignment 
procedure for patellar subluxation or trochlear dysplasia. Furthermore, the results
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from our study demonstrate that patients who were younger than 50 years of age 
at the time of the primary procedure did not have a higher risk of revision for any 
reason than did patients who were older than 50 years. No differences in revision 
rate between female and male patients were found. The rate of revision in obese 
patients (body mass index >30 kg/m2) was higherthan that in non-obese patients. 
The main mode of failure of the Richards II patellofemoral joint replacement was 
development of painful femorotibial osteoarthritis, which necessitated conversion 
to total knee replacement in 13% of knees a mean of 12 years after the primary 
operation.
In Chapter 4, we assess the clinical results of converting patellofemoral joint 
replacement to total knee replacement for the development of painful femorotibial 
osteoarthritis. Using a matched case-control study, we found that patellofemoral 
joint replacement does not have a negative effect on the clinical outcome of 
later total knee replacement as assessed with standardised clinical and patient­
relevant outcome measures. In the patellofemoral conversion group, however, a 
high number of manipulations under anaesthesia for failure to achieve 90 degrees 
of flexion by 6 weeks postoperatively were noted. The reason for this elevated 
manipulation rate remains unresolved.
The results presented in Chapter 5 show that Richards II patellofemoral joint 
replacement leads to a statistically significant decrease in bone mineral density 
behind the anterior flange of the femoral component. The bone mineral density 
was assessed using dual-energy X-ray absorptiometry (DXA) before and 1 year 
after arthroplasty.
Chapter 6 describes a finite element analysis of distal femoral stress distributions 
after patellofemoral joint replacement. We modelled a patellofemoral joint in a 
dynamic finite element knee model w ithout patellofemoral replacement and with 
replacement using the Journey PFJ patellofemoral prosthesis, the Richards II 
patellofemoral prosthesis, and the Genesis II total knee prosthesis with patellar 
resurfacing. For each of the 4 finite element models, the bone stress distributions 
in the same 2 regions of interest described in the previous chapter were evaluated 
during a squatting movement of 120° of flexion. Our modelling predicted a higher 
degree of stress-shielding in the anterior region of interest with the Richards II 
patellofemoral prosthesis compared with the Journey PFJ prosthesis, and the 
Genesis II total knee prosthesis demonstrated the highest degree of stress-
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shielding. The differences between the observed degrees of stress-shielding with 
the 2 patellofemoral designs may be related to specific design properties.
Chapter7 describes the results of a postal questionnaire sentto all 98 orthopaedic 
departments in The Netherlands. The questions focused on the frequency of total 
knee replacements, patellar resurfacing, and the use of circumpatellar 
electrocautery in total knee replacement. In summary, of the orthopaedic surgeons 
performing knee replacements, 13% always use patellar resurfacing in total knee 
replacement for osteoarthritis, 49% use selective patellar resurfacing, and 38% 
never use it. Fifty-six percent of orthopaedic surgeons use circumpatellar 
electrocautery when not resurfacing the patella, and 32% use electrocautery 
when resurfacing the patella. These results show there is no consensus among 
Dutch orthopaedic surgeons on the use of patellar resurfacing or electrocautery 
of the patellar rim in total knee replacement performed for osteoarthritis.
In Chapter 8, we studied the efficacy of circumpatellar electrocautery in total 
knee replacement without patellar resurfacing in a prospective, outcome-assessor 
and patient-blinded, parallel group, randomised clinical trial. Our study shows 
that in patients with primary knee osteoarthritis having total knee arthroplasty 
w ithout patellar resurfacing, the use of circumpatellar electrocautery results in a 
lower prevalence of anterior knee pain at the 1-year follow-up compared with no 
circumpatellar electrocautery, with a relative risk reduction of 40% for postsurgical 
anterior knee pain. Moreover, we found better WOMAC scores in the intervention 
group, mostly because of better scores in the function component of the WOMAC, 
suggesting that anterior knee pain may be associated with the functional results.
Comparison with other studies
Presently, there are no other published peer-reviewed systematic reviews 
describing the results of nonoperative and operative treatment modalities in 
isolated patellofemoral osteoarthritis. Therefore, we were unable to compare our 
findings and recommendations with other high quality sources. The value of 
narrative reviews is obviously hampered by selection bias and reporting bias.
The long-term outcomes of patellofemoral joint replacement have been reported 
by other authors (Kooijman et al. 2003, Cartier et al. 2005, Argenson et al. 2005).
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Our results show cumulative survivals of 84% (95% confidence Interval, 78-90%) 
at 10 years and 69% (95% confidence Interval, 59-79%) at 20 years with the 
Richards II patellofemoral prosthesis. This conversion rate Is superior to the 
long-term follow-up revision rates described In the literature, although no 
confidence Intervals for the survival data were previously reported (Cartier et al.
2005, Argenson et al. 2005). We also Investigated the Influence of diagnostic 
group on the long-term outcomes because some authors reported better 
outcomes In patients with patellofemoral Instability (Arclero and Toomey 1988, 
Argenson et al. 1995, Argenson et al. 2005) or posttraumatlc patellofemoral 
osteoarthritis (Argenson et al. 1995). Because these authors performed no 
statistics, the value of their observations Is obviously limited. Similarly, some 
researchers reported better outcomes In female patients (Arclero and Toomey 
1988, Krajca-Radcllffe and Coker 1996). We found that diagnosis, sex, or age at 
time of patellofemoral joint replacement does not Influence the outcome.
The Australian Orthopaedic Association National Joint Replacement Registry 
stated the revision rates for several patellofemoral prosthetic designs In Its 2009 
Annual Report (Australian Orthopaedic Association National Joint Replacement 
Registry 2009). These revision rates should be Interpreted with care because only 
more detailed data on the reasons for revision will enable us to directly compare 
the different patellofemoral designs In use. Most conversions to total knee 
replacement are performed because painful femorotlblal osteoarthritis develops 
and are not prosthesis related (e.g., malposltlonlng, loosening, and/or wear of the 
prosthesis) (Leadbetter et al. 2005). Moreover, some Investigators consider 
patellofemoral joint replacement a ‘bridging procedure’ since It Is not as major a 
procedure as primary total knee replacement (Leadbetter et al. 2005, Argenson 
et al. 2005, Lonner 2007, Farr and Barrett 2008). The higher risk of later conversion 
to total knee replacement Is accepted largely because It was thought that 
conversion would be relatively straightforward and have a similar outcome to that 
of primary total knee replacement. Indeed, several case series reported 
Improvement In post-revlslon outcome scores compared with pre-operative 
scores In patients undergoing revision surgery (Slsto and Cook 1997, Lonner et al.
2006, Porteous et al. 2007). However, less favourable results were observed after 
revision for technical error or unexplained pain (Mulford et al. 2009). Because the 
main reason for revision Is painful femorotlblal osteoarthritis, we specifically 
Investigated whether the clinical results after conversion for femorotlblal 
osteoarthritis were comparable to those after primary total knee replacement and
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found comparable results. The revision procedure was straightforward with no 
technical difficulties, which was noted by others as well (Lonner et al. 2006, 
Mulford et al. 2009). To overcome the need to revise the patellar resurfacing, the 
patellar button In patellofemoral joint replacement should be compatible with 
current total knee designs (Argenson et al. 2005). We did not evaluate the revision 
rate among secondary total knee replacements. In the future, the results of 
nationwide joint registries may demonstrate an Increased rate of revision among 
the secondary total knee replacements, as this Is a concern with medial uni­
compartmental knee replacements (Australian Orthopaedic Association National 
Joint Replacement Registry 2009).
After total knee replacement, the bone mineral density of the distal femur, as 
assessed by DXA, decreases by 16% to 36% within 1 year because of the femoral 
com ponent’s stress-shielding effect (Petersen et al. 1995, Splttlehouse et al. 
1999, van Loon et al. 2001, Solnlnvaara et al. 2004). Likewise, our DXA study 
shows that Richards II patellofemoral joint replacement results In peri prosthetic 
femoral bone loss (15%). This was an unexpected finding because the femoral 
component is markedly smaller in size.
Finite element analyses are used extensively in the evaluation of prosthetic load 
and bone remodelling after total hip and knee replacement (Qian et al. 2009, Zelle 
et al. 2009). However, no previous peer-reviewed publications report the use of 
finite element analysis to evaluate distal femoral stress distributions after 
patellofemoral joint replacement. Therefore, no direct comparison with other 
studies is possible. The results of finite element analysis in total knee replacement, 
however, show that with a bonded femoral component, the predicted long-term 
bone loss occurs at the most distal part of the femur and behind the anterior part 
of the prosthesis (Tissakht et al. 1996, van Lenthe et al. 1997). This is in accordance 
with our findings.
Circumpatellar electrocautery denervation is used by a number of orthopaedic 
surgeons to reduce the prevalence of anterior knee pain after total knee 
arthroplasty. Only one previous clinical study reported results on patellar rim 
electrocautery (Saoud 2004). Unfortunately, the design of this study precludes 
drawing conclusions about the efficacy of the procedure. After our study was 
completed, Gupta et al. reported a lack of improvement after patellar rim 
electrocautery in total knee arthroplasty w ithout patellar resurfacing (Gupta et al.
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2010b). The procedures used in this retrospective, comparative cohort study 
leave much to be desired because matching was only done for age and sex while 
introducing substantial bias by comparing results from two different surgeons; 
one performing electrocautery and the other not.
A multitude of studies assess the various factors thought to be related to anterior 
knee pain, including patient characteristics (Wood et al. 2002, Smith et al. 2004), 
degree of patellar cartilage wear (Rodriguez-Merchan and Gomez-Cardero 2010), 
prosthetic design (Popovic and Lemaire 2003, Skwara et al. 2008, Breugem et al. 
2008), operative technique (Fern et al. 1992, Barrack et al. 2001b, Maculé et al. 
2005), and the use of patellar resurfacing (Wood et al. 2002, Waters and Bentley
2003, Calvisi et al. 2009). Although some of these factors could be related to 
denervation, others are not. It is thus probable that the occurrence of anterior 
knee pain after total knee replacement is multifactorial. Patellar resurfacing 
requires removal of synovial and fibrous tissue around the patellar rim to enable 
accurate resection and restore patellar thickness. Therefore, the lower prevalence 
of postsurgical anterior knee pain after total knee replacement with patellar 
resurfacing may be the result of denervation. In these cases, additional 
electrocautery of the patellar rim may not result in a further reduction in the 
prevalence of anterior knee pain.
Strengths and limitations
The systematic review presented in Chapter 2 was performed using both well- 
articulated patient-oriented clinical questions (PICO) and an evaluation with the 
GRADE approach to obtain an evidence-based discussion of nonoperative and 
operative treatment options in isolated patellofemoral osteoarthritis (Atkins et al.
2004, Petrisor et al. 2006, Guyatt et al. 2008). There is, however, always a 
possibility that we have failed to identify some studies, although a comprehensive 
search strategy was used including visually searching the reference lists of all 
eligible articles. Furthermore, because there are currently no standardised 
diagnostic criteria for patellofemoral osteoarthritis, it is possible that we included 
studies with important heterogeneity regarding the degree of osteoarthritis and 
clinical complaints. Our systematic review shows that the current best available 
evidence for treating isolated patellofemoral osteoarthritis is sparse and generally 
of low methodological quality. The lack of randomised controlled studies may
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have resulted In substantial selection bias. Also, comparing the results of different 
treatments was hampered by the extensive heterogeneity among the outcome 
Instruments used.
The strengths of our follow-up study (Chapter 3) on the outcomes of the Richards 
II patellofemoral joint replacement Include the median 13.3 (range, 2 to 30.6) 
years of follow-up and findings that correlate the long-term survival of patellofemoral 
joint replacement with primary diagnosis, age, sex, and body mass Index. 
Furthermore, our study describes the results of all consecutive Richards II 
patellofemoral joint replacements performed at Deventer hospital from 1976 
onwards with only 4 of 185 patients lost to follow-up. With a maximum follow-up 
of more than 30 years, however, the use of the same clinical scoring system for all 
cases was not feasible, which eliminated our ability to compare preoperative and 
follow-up clinical scores for the group as a whole.
Our retrospective case-control study (Chapter 4) Is the first to compare the 
outcome of patients with a patellofemoral joint replacement converted to a total 
knee replacement for femorotlblal osteoarthritis with that of a matched group of 
patients with a primary total knee replacement for femorotlblal osteoarthritis. 
Thus, the study Is strengthened by having Included only patients needing 
conversion for femorotlblal osteoarthritis and not Including failures owing to 
patellar maltracklng or Incorrect diagnosis. An Important limitation, however, Is 
that potential differences In Improvement between the two groups were not 
evaluated because preoperative Knee Society knee scores (KSKS), Knee Society 
function scores (KSFS), and WOMAC scores for the entire group were not 
available.
The study described In Chapter 5 Is strengthened by being the first prospective 
clinical study specifically designed to address the Issue of potential loss of 
femoral bone after patellofemoral joint replacement. We assessed the bone 
mineral density using DXA both preoperatlvely and at the 1 year follow-up; 
however, It Is possible that further decreases In bone mineral density occur In our 
patients. Furthermore, the preoperative DXA measurements were used as 
baseline; we cannot rule out the possibility that the prosthesis Influenced the DXA 
measurements, even though knee-specific software was used. Although our 
study protocol excluded medical conditions that could have affected the bone 
mineral density, It Is possible that other conditions may have existed that Influenced
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the results. None of the patients had a severe medical disability that limited their 
ability to walk or had a disabling disease Involving other joints of the lower 
extremities. Regression analysis of the change from baseline bone mineral density 
for both regions of Interest against body mass Index, age, and sex demonstrated 
no significant relationships. However, we did not assess the amount of physical 
activity at the 1-year follow-up and therefore were not able to evaluate possible 
relationships with change from baseline bone mineral density.
The strengths of our finite element analysis (Chapter 6) to evaluate distal femoral 
stress distributions after patellofemoral joint replacement Include comparing the 
stress-shielding effect of 3 different patellofemoral replacement designs, and 
verification of the results against those In the previous chapter. However, finite 
element modelling Is associated with limitations owing to Inherent uncertainties 
concerning material properties, geometry, and load situation.
Strengths of the postal survey study (Chapter 7) Include the high response rate 
(92%) and that our study Is the first to determine the prevalence of clrcumpatellar 
electrocautery and patellar resurfacing performance among orthopaedic 
surgeons. To reduce the chance of a non-response bias, we Improved the 
response rate by designing a mlxed-mode (mall and telephone) survey and using 
the appropriate strategies suggested by others (Sprague et al. 2009).
The study described In Chapter 8 Is the first prospective, outcom e-assessor and 
patient-blinded, parallel group, randomised clinical trial to study the effect of 
clrcumpatellar electrocautery In total knee replacement w ithout patellar 
resurfacing. We followed the CONSORT guidelines for reporting clinical trials of 
non-pharm acologlc treatments (Boutron et al. 2008a, Boutron et al. 2008b). 
The CONSORT statement Is Intended to Improve the reporting of a randomised 
controlled trial, enabling readers to understand a tria l’s design, conduct, analysis 
and Interpretation, and to assess the validity of Its results. Generallsablllty 
describes the extent to which research findings can be applied to settings other 
than that In which they were originally tested. To enhance the generallsablllty of 
our research findings, we used broad Inclusion criteria and maximised the sample 
size. The study was undertaken at a general teaching hospital by 5 different 
general orthopaedic surgeons using a commonly used prosthesis. Furthermore, 
validity was maximised by randomisation and allocation concealment, adequate 
blinding, careful follow-up with no patients lost to follow-up, and use of both
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standardised clinical and patient-reported outcomes. Most importantly, we used 
outcome measures important to patients rather than surrogate endpoints 
(Poolman 2009). We followed our patients for 1 year. Some authors (Wood et al.
2002, Arbuthnot et al. 2004) reported a gradual decrease in anterior knee pain 
after total knee replacement, whereas others (Campbell et al. 2006) describe an 
increase in the incidence over time. To assess the long-term outcomes, we will 
re-evaluate the patients in the future because the clinical effect of circumpatellar 
electrocautery may diminish over time.
Implications of this thesis
Methodologically good quality comparative studies, preferably using a patient­
relevant outcome instrument, are needed to establish the optimal treatment 
strategy for patients with isolated patellofemoral osteoarthritis. Presently, there is 
no convincing evidence that one specific treatment modality is superior to another 
in terms of better outcomes. Initially, patients with isolated patellofemoral 
osteoarthritis can be treated with a nonoperative approach, such as physical 
therapy, taping, or injection therapy. If nonoperative treatment fails to alleviate the 
symptoms, operative treatment using patellofemoral joint replacement may be 
considered for selected patients. Diagnosis, sex, or age at time of patellofemoral 
joint replacement do not influence outcome; however, obese patients may 
consider losing weight because higher revision rates are noted in obese patients. 
Although development of painful femorotibial osteoarthritis is a major reason for 
conversion to total knee replacement, our results show that the clinical outcome 
of total knee replacement is not influenced by prior patellofemoral joint replacement. 
However, during conversion to total knee replacement, decreased bone quality 
may be encountered behind the femoral component as a result of stress shielding. 
It is possible that this will lead to a higher revision rate among secondary knee 
replacements. With regard to anterior knee pain after total knee replacement, we 
suggest routine use of circumpatellar electrocautery to reduce the prevalence of 
anterior knee pain and to achieve better functional results.
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Future research
This thesis raises the following future research questions: (a) Which nonoperative 
and operative treatment modalities result in superior clinical outcomes in patients 
with isolated patellofemoral osteoarthritis? (b) How do the long-term outcomes of 
newer patellofemoral prostheses compare with those achieved with the Richards
II prosthesis? (c) How does the revision rate of secondary total knee replacements 
after conversion from patellofemoral joint replacement compare with the revision 
rate of primary total knee replacements? (d) What is the source of anterior knee 
pain after total knee replacement? (e) Is the lower prevalence of anterior knee 
pain in patients with total knee replacement with patellar resurfacing a result of 
denervation because of the requirement to remove synovial tissue to enable 
resurfacing? (f) What would the clinical outcome of patellofemoral joint replacement 
be without patellar resurfacing?
Conclusions
With regard to the aims of this thesis:
■ The role of nonoperative and operative treatment modalities in isolated patello­
femoral osteoarthritis needs further study;
■ The long-term outcomes of the Richards II patellofemoral joint replacement are 
not influenced by diagnosis, sex, or age at time of patellofemoral joint 
replacement, and development of painful femorotibial osteoarthritis is the main 
mode of failure;
■ Prior patellofemoral joint replacement has no effect on the clinical outcome of 
later conversion to total knee replacement for femorotibial osteoarthritis;
■ The stress-shielding effect of the femoral component in the Richards II 
patellofemoral joint replacement results in a decrease in the bone mineral 
density in the periprosthetic femur;
■ Circumpatellar electrocautery in total knee replacement is used by approximately 
50% of orthopaedic surgeons in The Netherlands. The use of electrocautery 
results in a lower prevalence of anterior knee pain and better functional 
results.
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Hoofdstuk 10
Achtergrond
Geïsoleerde patellofemorale artrose Is een degeneratleve aandoening van de 
knie die bij ongeveer 4 tot 24% van de patiënten met artrose van de knie voorkomt 
(Barrett, Jr. et al. 1990, McAIIndon et al. 1992, Davles et al. 2002). Matige geïsoleerde 
patellofemorale artrose Is geassocieerd met pijn, stijfheid en functieverlies (Hunter 
et al. 2003, Duncan et al. 2009). De meeste patiënten kunnen succesvol worden 
behandeld met een nlet-operatleve benadering. Voor patiënten met Invaliderende 
pljnklachten na falen van conservatieve therapie zijn verschillende operatieve 
behandelmethodes beschreven, en patellofemorale gewrlchtsvervanglng Is voor 
geselecteerde patiënten een behandeloptle (Grelsamer and Steln 2006, Leadbetter 
et al. 2006).
Bij patellofemorale gewrlchtsvervanglng worden de femorotlblale gewrlchtscom- 
partlmenten evenals de menlscl en kruisbanden ongemoeid gelaten, zodat 
mogelijk de fysiologische klnematlca van de knie behouden blijft. De beschreven 
klinische resultaten van patellofemorale gewrlchtsvervanglng zijn afhankelijk van 
patlëntenselectle, geometrische eigenschappen van de prothese en de operatie­
techniek (Leadbetter et al. 2005, Leadbetter et al. 2006, Gupta et al. 2010a). Het 
ontwikkelen van pijnlijke femorotlblale artrose na patellofemorale gewrlchtsver­
vanglng Is een belangrijke reden voor conversie naar een totale knlevervanglng, 
en voorspellende factoren zijn vooralsnog niet bekend. De resultaten van 
conversie worden mogelijk negatief beïnvloed door de eerdere patellofemorale 
gewrlchtsvervanglng.
Problemen voortkomend uit het patellofemorale gewricht vormen de belangrijkste 
nlet-lnfectleuze reden voor revlsleoperatles na primaire totale knlevervanglng 
(Elsenhuth et al. 2006). Sommige orthopedisch chirurgen maken tijdens totale 
knlevervanglng gebruik van electrocauterlsatle (dlathermle) rond de patella om 
de prevalentie van anterleure kniepijn te verminderen.
Doel van dit proefschrift
De doelstellingen van dit proefschrift werden als volgt geformuleerd:
■ Het verhelderen van de rol van nlet-operatleve en operatieve behandelmethodes 
bij geïsoleerde patellofemorale artrose;
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■ Het evalueren van de langetermljnresultaten van een patellofemorale prothese 
en het Identificeren van de verschillende faalmechanlsmen;
■ Het onderzoeken van het effect van eerdere patellofemorale gewrlchtsvervanglng 
op de klinische resultaten van latere conversie naar totale knlevervanglng 
wegens femorotlblale artrose;
■ Het evalueren van mogelijk verlies van femoraal bot na patellofemorale gewrlchts­
vervanglng;
■ Het onderzoeken van de werkzaamheid van electrocauterlsatle rond de patella 
bij totale knlevervanglng.
De belangrijkste bevindingen van dit proefschrift
Hoofdstuk 2 beschrijft de resultaten van een systematisch literatuuroverzicht van 
de nlet-operatleve en operatieve behandelmethodes bij geïsoleerde patello­
femorale artrose. Onze resultaten laten zien dat er momenteel geen publicaties 
zijn die de langetermljnresultaten (meerdan 1 jaar) van nlet-operatleve behandeling 
beschrijven. Een groot aantal methodologisch zwakke studies beschrijft de korte- 
en langetermljnresultaten van operatieve behandeling. Ondanks deze beperkingen 
presenteren wij aanbevelingen voor de behandeling van geïsoleerde patello­
femorale artrose gebaseerd op het hoogst beschikbare niveau van bewijs. 
Gebruik makend van de GRADE-methodlek (Gradlng of Recommendatlons 
Assessment, Development and Evaluatlon) hebben wij voor Iedere Interventie 
zowel een aanbeveling voor het gebruik In de klinische praktijk, als de kwaliteit 
van het beschikbare bewijs voor deze aanbeveling beoordeeld. Nlet-operatleve 
behandeling met fysiotherapie (GRADE: hoge kwaliteit, zwakke aanbeveling voor 
gebruik), tapebehandellng (GRADE: matige kwaliteit, zwakke aanbeveling voor 
gebruik), en Intra-artlculalre Injecties (GRADE: heel lage kwaliteit, zwakke 
aanbeveling voor gebruik) kunnen resulteren In tijdelijke vermindering van 
klachten. Een niet-gewrichtsvervangende operatieve behandeling kan resulteren 
in onvoldoende, onvoorspelbare of alleen kortdurende vermindering van klachten 
(GRADE: lage kwaliteit, zwakke aanbeveling tegen gebruik). Totale knievervanging 
met patellaresurfacing resulteert in voorspelbare en duurzaam goede resultaten 
(GRADE: lage kwaliteit, zwakke aanbeveling voor gebruik). De resultaten van een 
patellofemorale gewrichtsvervanging zijn bij geselecteerde patiënten goed tot 
uitstekend (GRADE: lage kwaliteit, zwakke aanbeveling voor gebruik).
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De langetermijnresultaten van de Richards II patellofemorale prothese worden 
beschreven In hoofdstuk 3. Na een medlane follow-up van 13,3 jaar bij 181 
patellofemorale gewrlchtsvervanglngen vonden wij geen verschil In overleving 
van de prothese tussen patiënten met primaire geïsoleerde patellofemorale 
artrose, posttraumatische patellofemorale artrose en patellofemorale artrose met 
een patella-stablllserende Ingreep In het verleden. Daarnaast laten de resultaten 
van ons onderzoek zien dat patiënten jonger dan 50 jaar op het moment van de 
patellofemorale gewrlchtsvervanglng geen grotere kans op revisie hebben dan 
patiënten ouder dan 50. De overleving van de prothese Is bij mannen en vrouwen 
gelijk. De kans op revisie Is bij obese patiënten (BMI > 30 kg/m2) hoger dan bij 
nlet-obese patiënten. Het belangrijkste faalmechanlsme van de Richards II 
patellofemorale gewrlchtsvervanglng Is het ontwikkelen van pijnlijke femorotlblale 
artrose, welke bij 13% van de knieën na gemiddeld 12 jaar conversie naar totale 
knlevervanglng noodzakelijk maakte.
In hoofdstuk 4 worden de klinische resultaten van conversie van een patello­
femorale gewrlchtsvervanglng naar een totale knlevervanglng wegens femorotlblale 
artrose geëvalueerd In een patlënt-controleonderzoek. Wij vonden dat patello­
femorale gewrlchtsvervanglng geen negatief effect heeft op de klinische resultaten 
van latere totale knlevervanglng zoals gemeten met gestandaardiseerde klinische 
en patiënt relevante ultkomstlnstrumenten. In de conversie groep werd wel een 
relatief groot aantal manipulaties verricht wegens niet bereiken van 90 graden 
flexie na 6 weken. De oorzaken hiervoor zijn niet duidelijk.
De resultaten gepresenteerd In hoofdstuk 5 laten zien dat Richards II patello­
femorale gewrlchtsvervanglng resulteert In een statistisch significante vermindering 
van de botdichtheid achter de femorale component. De botdichtheid werd 
vastgesteld met ‘dual-energy X-ray absorptiometry’ (DXA) metingen verricht voor 
en 1 jaar na plaatsing van de prothese.
Hoofdstuk 6 beschrijft een eindige elementen analyse van de mechanische 
botspanningen in het femorale bot na patellofemorale gewrichtsvervanging. Vier 
verschillende eindige elementen modellen van het patellofemorale gewricht 
werden ontwikkeld: zonder patellofemorale gewrichtsvervanging, na patello­
femorale gewrichtsvervanging met de Journey PFJ patellofemorale prothese, na 
patellofemorale gewrichtsvervanging met de Richards II patellofemorale prothese 
en na totale knievervanging met de Genesis II prothese met patellaresurfacing.
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Voor elk van de 4 modellen werden de gemiddelde botspannlngen In dezelfde 2 
regio’s als beschreven In het vorige hoofdstuk bepaald tijdens een beweging van 
stand naar hurkzit met 120 graden flexie. Onze modellen voorspellen een hogere 
mate van afscherming van mechanische botspannlngen In de anterleure regio 
met de Rlchards II prothese In vergelijking met de Journey PFJ prothese, en de 
Genesis II totale knleprothese toonde de hoogste mate van afscherming van 
mechanische botspannlngen. De verschillen In de mate van afscherming van 
mechanische botspannlngen met de 2 patellofemorale protheses zijn mogelijk 
gerelateerd aan specifieke ontwerpkarakterlstleken.
Hoofdstuk 7 beschrijft de resultaten van een schriftelijke enquête verzonden 
naar alle 98 afdelingen orthopedie In Nederland. De vragenlijst richtte zich op het 
aantal totale knlevervanglngen, het gebruik van resurfaclng van de patella, en het 
gebruik van electrocauterlsatle rond de knieschijf bij totale knlevervanglngen. 
Van de orthopedisch chirurgen die knleprotheses plaatsen gebruikt 13% altijd 
patellaresurfaclng bij totale knlevervanglng wegens artrose, 49% plaatst selectief 
een patellacomponent en 38% gebruikt nooit patellaresurfaclng. Zesenvijftig 
procent van de orthopedisch chirurgen gebruikt electrocauterlsatle rond de 
patella Indlen de patella niet geresurfaced wordt, en 32% gebruikt electrocauterlsatle 
bij patellaresurfaclng. Deze resultaten laten zien dat onder Nederlandse orthopedisch 
chirurgen consensus ontbreekt als het gaat om resurfaclng en het gebruik van 
clrcumpatellalre electrocauterlsatle bij totale knlevervanglng wegens artrose.
In hoofdstuk 8 hebben wij In een prospectief, patiënt en ultkomstbeoordelaar 
geblindeerd, parallel gerandomiseerd onderzoek het effect van electrocauterlsa­
tle rond de knieschijf bij totale knlevervanglng zonder patellaresurfaclng 
bestudeerd. Onze resultaten laten zien dat bij patiënten met totale knlevervanglng 
zonder patellaresurfaclng, het gebruik van electrocauterlsatle rondom de patella 
resulteert In een lagere prevalentie van anterleure kniepijn na 1 jaar follow-up In 
vergelijking met geen electrocauterlsatle, met een relatieve risicoreductie van 
40%. Daarnaast vonden wij betere WOMAC scores In de Interventlegroep, vooral 
door de betere scores In de functlecomponent van de WOMAC. Dit suggereert 
dat anterleure kniepijn mogelijk gerelateerd Is aan de functionele resultaten.
134
Hoofdstuk 10
Vergelijking met andere studies
Op dit moment zijn er geen gepubliceerde systematische literatuuroverzichten 
die de resultaten van niet-operatieve en operatieve behandelmethodes bij 
geïsoleerde patellofemorale artrose beschrijven. Wij kunnen daarom onze 
resultaten niet vergelijken met de bevindingen en aanbevelingen van andere hoge 
kwaliteit studies. De waarde van de beschikbare verhalende (‘narratieve’) literatuur­
overzichten is uiteraard beperkt door selectie- en publicatiebias.
De langetermijnresultaten van patellofemorale gewrichtsvervanging werden door 
verschillende auteurs beschreven (Kooijman et al. 2003, Cartier et al. 2005, 
Argenson et al. 2005). Onze resultaten laten een cumulatieve overleving van de 
Richards II patellofemorale prothese zien van 84% (95% betrouwbaarheidsinterval, 
78%-90%) na 10 jaar, en 69% (95% betrouwbaarheidsinterval, 59%-79%) na 20 
jaar. Deze cumulatieve overleving is beter dan de door andere auteurs beschreven 
langetermijn overleving, hoewel door hen geen betrouwbaarheidsintervallen 
werden gemeld (Cartier et al. 2005, Argenson et al. 2005). Wij onderzochten ook 
de invloed van de diagnostische groep op de langetermijnresultaten omdat 
sommige onderzoekers betere uitkomsten beschreven bij patiënten met patello­
femorale instabiliteit (Arciero and Toomey 1988, Argenson et al. 1995, Argenson 
et al. 2005) en posttraumatische patellofemorale artrose (Argenson et al. 1995). 
Aangezien geen van deze onderzoekers gebruik hebben gemaakt van statistiek 
is de waarde van hun observaties beperkt. Een aantal auteurs beschreven betere 
resultaten bij vrouwelijke patiënten (Arciero and Toomey 1988, Krajca-Radcliffe 
and Coker 1996). Wij vonden dat de diagnostische groep, het geslacht, of de 
leeftijd bij operatie geen invloed heeft op de klinische uitkomst.
In het Jaarverslag 2009 van de ‘Australian Orthopaedic Association National Joint 
Replacement Registry’ worden de revisierisico’s van verschillende typen patello­
femorale protheses beschreven (Australian Orthopaedic Association National 
Joint Replacement Registry 2009). Deze revisierisico s moeten voorzichtig worden 
geïnterpreteerd omdat vergelijken van de verschillende protheses alleen mogelijk 
is als de specifieke redenen voor revisie bekend zijn. De meeste conversies naar 
totale knievervanging worden verricht wegens de ontwikkeling van pijnlijke 
femorotibiale artrose en niet vanwege prothese gerelateerde factoren, zoals 
malpositie, loslating en/of slijtage van de prothese (Leadbetter et al. 2005). 
Bovendien stellen sommige onderzoekers dat patellofemorale gewrichtsvervanging
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beschouwd kan worden als een ‘overbrugglngs’-operatle omdat het een relatief 
beperkte Ingreep Is, en later alsnog kan worden geconverteerd naar totale 
knlevervanglng (Leadbetter et al. 2005, Argenson et al. 2005, Lonner 2007, Farr 
and Barrett 2008). De grotere kans op latere conversie naar totale knlevervanglng 
wordt daarbij geaccepteerd omdat zij stellen dat conversie relatief eenvoudig Is 
en de klinische uitkomsten vergelijkbaar zijn met de uitkomsten na primaire totale 
knlevervanglng. Inderdaad laten enkele observatlonele studies een verbetering 
van de ultkomstscores na conversie zien (Slsto and Cook 1997, Lonner et al. 
2006, Porteous et al. 2007). Minder gunstige resultaten werden echter 
geobserveerd na revisie wegens onbegrepen pijn of suboptlmaal plaatsen van 
de patellofemorale prothese (Mulford et al. 2009). Omdat de ontwikkeling van 
pijnlijke femorotlblale artrose de belangrijkste reden voor revisie Is, hebben wij 
specifiek onderzocht of de klinische resultaten na conversie wegens femorotlblale 
artrose vergelijkbaar zijn met de resultaten na primaire totale knlevervanglng, en 
wij vonden vergelijkbare resultaten. Overigens was de revlsleoperatle relatief 
eenvoudig zonder technische problemen, hetgeen ook door andere auteurs werd 
gemeld (Lonner et al. 2006, Mulford et al. 2009). Om te voorkomen dat ook de 
patellacomponent gereviseerd moet worden, Is het noodzakelijk dat de patella- 
component bij patellofemorale gewrlchtsvervanglng compatibel Is met de 
momenteel gebruikte totale knlesystemen (Argenson et al. 2005). Wij hebben de 
kans op revisie bij de secundaire knlevervanglngen niet bestudeerd. Het Is 
mogelijk dat de resultaten van nationale Implantatenreglstratles In de toekomst 
een verhoogde kans op revisie laten zien bij deze secundair verrichte totale knle­
vervanglngen, aangezien dit momenteel een punt van zorg Is bij de mediale 
hemlknlevervanglngen (Australian Orthopaedic Association National Joint 
Replacement Registry 2009).
Na totale knlevervanglng vermindert de met DXA vastgestelde botdlchtheld van 
het distale femur met 16 tot 36% binnen het eerste jaar doordat de femorale 
component een deel van de mechanische botspanningen opvangt (Petersen et 
al. 1995, Spittlehouse et al. 1999, van Loon et al. 2001, Soininvaara et al. 2004). 
Onze DXA studie laat zien dat Richards II patellofemorale gewrichtsvervanging 
evenzo resulteert in periprothetisch botverlies (15%). Dit hadden wij niet verwacht 
aangezien de femorale component van een patellofemorale prothese aanmerkelijk 
kleiner is dan die van een totale knieprothese.
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Eindige elementen analyses worden op uitgebreide schaal gebruikt bij de 
evaluatie van krachtinwerking op protheses en botremodellering na totale knie- 
en heupvervanging (Qian et al. 2009, Zelle et al. 2009). Er zijn echter geen eerdere 
publicaties die de resultaten van eindige elementen analyse bij de beoordeling 
van mechanische botspanningen in het distale femur na patellofemorale 
gewrichtsvervanging beschrijven. Directe vergelijking met andere studies is 
daardoor niet mogelijk. De resultaten van eindige elementen analyse bij totale 
knievervanging laten echter zien dat het voorspelde botverlies bij een goed 
gefixeerde femorale component optreedt in het meest distale deel van het femur 
en direct achter het voorste deel van de prothese (Tissakht et al. 1996, van Lenthe 
et al. 1997). Dit is in overeenstemming met onze bevindingen.
Sommige orthopedisch chirurgen gebruiken circumpatellaire electrocauterisatie 
om de prevalentie van postoperatieve pijnklachten aan de voorzijde van de knie 
na totale knievervanging te verminderen. Slechts één klinische studie beschreef 
de resultaten van circumpatellaire diathermie (Saoud 2004). Helaas laat de 
gebruikte studieopzet geen conclusies toe betreffende de effectiviteit van de 
procedure. Nadat onze studie was beëindigd, beschreven Gupta et al. het 
ontbreken van verbetering na electrocauterisatie rondom de patella bij totale 
knievervanging zonder resurfacing (Gupta et al. 2010b). De onderzoeksmethoden 
van deze retrospectief vergelijkende studie laten echter veel te wensen over, daar 
'matching' alleen gedaan werd voor leeftijd en geslacht, en belangrijke bias werd 
geïntroduceerd door de resultaten van twee verschillende chirurgen te vergelijken; 
de een gebruikte wel electrocauterisatie, en de ander niet.
Een veelheid van studies heeft de verschillende factoren bestudeerd die mogelijk 
gerelateerd zijn aan anterieure kniepijn: patiënt karakteristieken (Wood et al. 
2002, Smith et al. 2004), de mate van degeneratieve veranderingen van de patella 
(Rodriguez-Merchan and Gomez-Cardero 2010), ontwerpkarakteristieken van de 
prothese (Popovic and Lemaire 2003, Skwara et al. 2008, Breugem et al. 2008), 
operatietechniek (Fern et al. 1992, Barrack et al. 2001b, Maculé et al. 2005) en het 
gebruik van patellaresurfacing (Wood et al. 2002, Waters and Bentley 2003, 
Calvisi et al. 2009). Het is mogelijk dat een aantal van deze factoren gerelateerd 
is aan denervatie, voor andere variabelen geldt dit niet. Het lijkt dus aannemelijk 
dat het optreden van anterieure kniepijn na totale knievervanging multifactorieel 
bepaald is. Overigens vereist patellaresurfacing dat synovium en fibreus weefsel 
rondom de patella verwijderd wordt zodat accuraat kan worden gereseceerd en
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de patelladikte kan worden hersteld. De lagere prevalentie van anterleure kniepijn 
na totale knlevervanglng mèt patellaresurfaclng kan dus het gevolg zijn van 
denervatle. Additionele electrocauterlsatle rondom de patellaresurfaclng resulteert 
dan mogelijk niet In een verdere afname van de prevalentie van anterleure kniepijn.
Enkele sterke en zwakke punten van het onderzoek
Het systematisch literatuuroverzicht beschreven In hoofdstuk 2 Is het eerste 
literatuuroverzicht dat gebruik maakt van zowel helder geformuleerde patiënt 
georiënteerde klinische vragen (PICO) als van een evaluatie met de GRADE 
benadering om te komen tot een op bewijs gebaseerde bespreking van de niet- 
operatleve en operatieve behandelmethodes bij geïsoleerde patellofemorale 
artrose (Atklns et al. 2004, Petrlsor et al. 2006, Guyatt et al. 2008). Het Is uiteraard 
mogelijk dat wij enkele studies niet hebben geïdentificeerd, hoewel wij gebruik 
maakten van een zorgvuldige zoekstrategie Inclusief het visueel controleren van 
de literatuurverwijzingen van de geïncludeerde artikelen. Omdat er geen 
gestandaardiseerde diagnostische criteria voor patellofemorale artrose zijn, Is 
het mogelijk dat wij onderzoeken hebben geïncludeerd met belangrijke verschillen 
In de mate van degeneratleve veranderingen en ernst van de klachten. Ons 
systematisch literatuuroverzicht laat zien dat het best beschikbare bewijs voor de 
behandeling van geïsoleerde patellofemorale artrose schaars Is en over het algemeen 
van zwakke methodologische kwaliteit. Het ontbreken van gerandomiseerde 
onderzoeken (RCTs) kan hebben geresulteerd In een belangrijke selectleblas. 
Daarnaast werd het vergelijken van de resultaten van de verschillende behandel­
methodes bemoeilijkt door belangrijke verschillen In de gebruikte ultkomstmaten.
De sterke punten van ons onderzoek naar de langetermljnresultaten (hoofdstuk 
3) van de Rlchards II patellofemorale prothese zijn de medlane follow-up van 13,3 
(2 tot 30,6) jaar en het onderzoek naar overleving van de prothese gerelateerd 
aan factoren als primaire diagnose, leeftijd, geslacht en BMI. Daarnaast worden 
In onze studie de resultaten beschreven van alle opeenvolgende Rlchards II pa­
tellofemorale gewrlchtsvervanglngen die vanaf 1976 In Deventer zijn verricht, met 
een uitval uit de nacontroles van slechts 4 van de 185 patiënten. Met een maximale 
follow-up van meer dan 30 jaar is gebruik van dezelfde klinische score echter niet 
mogelijk, waardoor vergelijking tussen preoperatieve en postoperatieve scores 
niet voor de gehele groep patiënten mogelijk was.
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Ons retrospectief patiënt-controleonderzoek (hoofdstuk 4) is de eerste studie 
die de resultaten vergelijkt tussen patiënten met een patellofemorale prothese 
geconverteerd naar een totale knievervanging wegens femorotibiale artrose en 
een 'gematchte' patiëntengroep met een primaire totale knievervanging wegens 
femorotibiale artrose. Het sterke punt van onze studie was het beperken van de 
onderzoekspopulatie met uitsluitend femorotibiale artrose als reden voor de 
revisie, en niet falen door problemen met de patellasporing of onjuiste diagnose. 
Een belangrijke beperking is echter dat de mogelijke verschillen in klinische 
verbetering tussen de 2 groepen niet werden beoordeeld aangezien de 
preoperatieve Knee Society knee scores (KSKS), Knee Society function scores 
(KSFS) en WOMAC scores niet voor alle patiënten beschikbaar waren.
Hoofdstuk 5 beschrijft de resultaten van de eerste prospectieve klinische studie 
die specifiek werd opgezet om het mogelijke verlies van femoraal bot na patello­
femorale gewrichtsvervanging te evalueren. Wij beoordeelden de botdichtheid 
met DXA zowel voor de operatie als 1 jaar na de operatie, en het is mogelijk dat 
een verdere afname van botdichtheid optreedt bij onze patiënten. De preoperatief 
bepaalde botdichtheid werd als uitgangswaarde gebruikt. Wij kunnen daarom 
niet uitsluiten dat de 1-jaars metingen beïnvloed zijn door de aanwezigheid van 
de prothese, zelfs met het gebruik van knie-specifieke software. Hoewel ons 
onderzoeksprotocol patiënten met een medische aandoening die de botdichtheid 
kan beïnvloeden excludeerde, is het mogelijk dat andere factoren de resultaten 
hebben beïnvloed. Geen van de patiënten had een ernstige medische beperking 
die het lopen beperkte, of een aandoening van de andere gewrichten aan de 
onderste extremiteit. Regressie analyse van de verandering van de botdichtheid 
versus de BMI, leeftijd en geslacht lieten geen significante relaties zien. Wij 
hebben echter niet specifiek naar de mate van lichaamsbeweging gekeken en 
zijn daarom niet in staat een relatie met de verandering van de botdichtheid te 
beoordelen.
De sterke punten van onze eindige elementen analyse (hoofdstuk 6) welke werd 
opgezet om de botspanningen in het femorale bot na patellofemorale gewrichts­
vervanging te evalueren zijn de vergelijking van 3 verschillende patellofemorale 
gewrichtsvervangingen en de verificatie van het model met de resultaten uit het 
vorige hoofdstuk. Het is echter mogelijk dat het door ons ontwikkelde model 
intrinsieke tekortkomingen bevat met betrekking tot geometrie, duur van de 
krachtinwerking en materiaaleigenschappen.
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Sterke punten van onze schriftelijke enquête (hoofdstuk 7) zijn de hoge respons 
van 92% en het feit dat onze studie de eerste is die de mate van het gebruik van 
electrocauterisatie rond de patella onder een grote groep orthopedisch chirurgen 
heeft vastgesteld. Om het risico op een non-respons bias te verminderen hebben 
wij een ‘mixed-mode’ (schriftelijke en telefonische) enquête gebruikt volgens de 
aanbevelingen van anderen (Sprague et al. 2009).
Het onderzoek beschreven in hoofdstuk 8 is het eerste prospectief, patiënt en 
uitkomstbeoordelaar geblindeerd, parallel gerandomiseerd onderzoek naar het 
effect van electrocauterisatie rond de knieschijf bij totale knievervanging zonder 
patellaresurfacing. Wij volgden de CONSORT richtlijnen voor het rapporteren van 
klinische studies van niet-farmacologische behandelingen (Boutron et al. 2008a, 
Boutron et al. 2008b). De CONSORT verklaring is bedoeld om de kwaliteit van 
rapporteren van een gerandomiseerde studie te verbeteren, zodat lezers de 
studieopzet, uitvoering, analyse en interpretatie van de trial kunnen begrijpen, en 
de validiteit van de verkregen resultaten kunnen beoordelen. De generaliseer- 
baarheid van een studie beschrijft de mate waarin de onderzoeksresultaten 
kunnen worden toegepast in een andere omgeving dan die waarin ze oorspronkelijk 
werden getest. Om de generaliseerbaarheid van onze onderzoeksresultaten te 
verbeteren, gebruikten wij ruime inclusiecriteria en een grote onderzoeksgroep. 
Het onderzoek werd uitgevoerd in een algemeen opleidingsziekenhuis waar 5 
orthopedisch chirurgen gebruik maakten van een veelgebruikte prothese. 
Validiteit van de resultaten werd zo groot mogelijk gemaakt door randomisatie en 
blindering van de behandelaar voor de toegewezen interventie, adequate 
blindering van patiënt en uitkomstbeoordelaar, nauwkeurige follow-up zonder 
verlies van patiënten voor nacontrole, en het gebruik van zowel gestandaardi­
seerde klinische scores als door patiënten beoordeelde uitkomsten. Nog 
belangrijker, wij gebruikten uitkomstmaten die belangrijk zijn voor patiënten, en 
geen surrogaat eindpunten (Poolman 2009). Wij volgden onze patiënten 
gedurende één jaar. Sommige auteurs (Wood et al. 2002, Arbuthnot et al. 2004) 
beschreven een geleidelijke afname van anterieure kniepijn na totale 
knievervanging, terwijl anderen (Campbell et al. 2006) een toename van de 
incidentie over de tijd rapporteerden. Om de langetermijnresultaten te beoordelen 
zullen wij onze patiënten in de toekomst herevalueren; het klinische effect van 
denerveren zou geleidelijk kunnen verminderen.
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Implicaties van dit proefschrift
Methodologisch goed opgezette vergelijkende onderzoeken, bij voorkeur gebruik 
makend van patiëntrelevante uitkomstinstrumenten, zijn nodig voor het bepalen 
van de optimale behandelstrategie voor patiënten met geïsoleerde patello- 
femorale artrose. Op dit moment is geen overtuigend bewijs voorhanden dat de 
ene behandelmethode voor wat betreft uitkomstinstrumenten beter is dan de 
andere. Initieel kunnen patiënten met een niet-operatieve benadering bestaande 
uit fysiotherapie, tapen en gewrichtsinjecties behandeld worden. Als de niet- 
operatieve behandeling faalt bij het verminderen van klachten kan bij geselecteerde 
patiënten operatieve behandeling met een patellofemorale gewrichtsvervanging 
worden overwogen. Diagnose, geslacht en leeftijd bij operatie beïnvloeden de 
overleving van de prothese niet. Wel moeten obese patiënten overwegen af te 
vallen omdat de overleving van de prothese korter is bij overgewicht. Hoewel het 
ontstaan van pijnlijke femorotibiale artrose een belangrijke reden voor conversie 
naar totale knievervanging is, laten onze onderzoeksresultaten zien dat de 
klinische resultaten van latere totale knievervanging niet negatief beïnvloed 
worden door de eerdere patellofemorale gewrichtsvervanging. Wel mag 
verminderde botdichtheid achter de femorale component van een patellofemorale 
prothese verwacht worden doordat de prothese een deel van de mechanische 
botspanningen opvangt. Dit zou aanleiding kunnen geven tot een verhoogde 
kans op revisie bij secundaire totale knievervangingen. Met betrekking tot 
anterieure kniepijn na totale knievervanging adviseren wij standaard gebruik van 
electrocauterisatie rondom de patella om de kans op anterieure kniepijn te 
verminderen en betere functionele resultaten te verkrijgen.
Toekomstig onderzoek
Dit proefschrift stelt de volgende onderzoeksvragen voor toekomstig onderzoek: 
(a) Welke niet-operatieve en operatieve behandelmethodes resulteren in de beste 
klinische resultaten bij patiënten met geïsoleerde patellofemorale artrose? (b) Zijn 
de langetermijnresultaten van nieuwe patellofemorale protheses vergelijkbaar 
met die van de Richards II prothese? (c) Is het risico op revisie bij secundaire 
totale knievervangingen na eerdere conversie van patellofemorale gewrichtsver­
vanging vergelijkbaar met het risico op revisie na primaire totale knievervangin-
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gen? (d) Wat is de oorzaak van anterieure kniepijn na totale knievervanging? (e) 
Is de lagere prevalentie van anterieure kniepijn na totale knievervanging mèt 
patellaresurfacing het gevolg van denervatie vanwege de vereiste excisie van 
synovium om te kunnen resurfacen? en (f) Hoe zijn de klinische resultaten na 
patellofemorale gewrichtsvervanging zónder patellaresurfacing?
Conclusies
Met betrekking tot de doelstellingen van dit proefschrift kunnen wij concluderen 
dat:
■ De rol van niet-operatieve en operatieve behandelingsmodaliteiten bij patiënten 
met geïsoleerde patellofemorale artrose verder onderzoek vereist;
■ De langetermijnresultaten van de Richards II patellofemorale gewrichts­
vervanging niet afhankelijk zijn van primaire diagnose, geslacht of leeftijd bij 
operatie, en het ontwikkelen van pijnlijke femorotibiale artrose de belangrijkste 
reden is voor conversie naar een totale knievervanging;
■ Voorgaande patellofemorale gewrichtsvervanging geen invloed heeft op de 
klinische resultaten van latere conversie naar een totale knievervanging wegens 
femorotibiale artrose;
■ Patellofemorale gewrichtsvervanging in een afname van de botdichtheid achter 
de femorale component resulteert doordat de prothese een deel van de 
mechanische botspanningen opvangt;
■ Electrocauterisatie rond de patella bij totale knievervanging door ongeveer de 
helft van de orthopedisch chirurgen in Nederland wordt gebruikt en dat electro­
cauterisatie in een lagere prevalentie van anterieure kniepijn resulteert met 
betere functionele resultaten.
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